0001482541 false Q1 2022 --12-31 Yes Yes
0001482541 2022-01-01 2022-03-31 0001482541
CEAD:CommonStock0.00001ParValueMember 2022-01-01 2022-03-31
0001482541 CEAD:WarrantsToPurchaseCommonStockMember 2022-01-01
2022-03-31 0001482541 2022-05-12 0001482541 2022-03-31 0001482541
2021-12-31 0001482541 2021-01-01 2021-03-31 0001482541
us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember
2021-12-31 0001482541 us-gaap:CommonStockMember 2021-12-31
0001482541 CEAD:CommonSharesToBeIssuedMember 2021-12-31 0001482541
us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001482541
us-gaap:RetainedEarningsMember 2021-12-31 0001482541
us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember
2020-12-31 0001482541 us-gaap:CommonStockMember 2020-12-31
0001482541 CEAD:CommonSharesToBeIssuedMember 2020-12-31 0001482541
us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001482541
us-gaap:RetainedEarningsMember 2020-12-31 0001482541 2020-12-31
0001482541 us-gaap:PreferredStockMember
us-gaap:SeriesAPreferredStockMember 2022-01-01 2022-03-31
0001482541 us-gaap:CommonStockMember 2022-01-01 2022-03-31
0001482541 CEAD:CommonSharesToBeIssuedMember 2022-01-01 2022-03-31
0001482541 us-gaap:AdditionalPaidInCapitalMember 2022-01-01
2022-03-31 0001482541 us-gaap:RetainedEarningsMember 2022-01-01
2022-03-31 0001482541 us-gaap:PreferredStockMember
us-gaap:SeriesAPreferredStockMember 2021-01-01 2021-03-31
0001482541 us-gaap:CommonStockMember 2021-01-01 2021-03-31
0001482541 CEAD:CommonSharesToBeIssuedMember 2021-01-01 2021-03-31
0001482541 us-gaap:AdditionalPaidInCapitalMember 2021-01-01
2021-03-31 0001482541 us-gaap:RetainedEarningsMember 2021-01-01
2021-03-31 0001482541 us-gaap:PreferredStockMember
us-gaap:SeriesAPreferredStockMember 2022-03-31 0001482541
us-gaap:CommonStockMember 2022-03-31 0001482541
CEAD:CommonSharesToBeIssuedMember 2022-03-31 0001482541
us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001482541
us-gaap:RetainedEarningsMember 2022-03-31 0001482541
us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember
2021-03-31 0001482541 us-gaap:CommonStockMember 2021-03-31
0001482541 CEAD:CommonSharesToBeIssuedMember 2021-03-31 0001482541
us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001482541
us-gaap:RetainedEarningsMember 2021-03-31 0001482541 2021-03-31
0001482541 2022-02-14 2022-02-15 0001482541 2021-12-30 0001482541
CEAD:TwoThousandAndTwentyThreeMember 2022-03-31 0001482541
srt:MinimumMember 2022-01-01 2022-03-31 0001482541
srt:MaximumMember 2022-01-01 2022-03-31 0001482541
CEAD:TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember
2022-01-01 2022-03-31 0001482541
us-gaap:CustomerConcentrationRiskMember
us-gaap:SalesRevenueNetMember CEAD:CustomerOneMember 2022-01-01
2022-03-31 0001482541 us-gaap:CustomerConcentrationRiskMember
us-gaap:SalesRevenueNetMember CEAD:CustomerOneMember 2021-01-01
2021-03-31 0001482541 us-gaap:CustomerConcentrationRiskMember
us-gaap:SalesRevenueNetMember CEAD:CustomerTwoMember 2021-01-01
2021-03-31 0001482541 us-gaap:CustomerConcentrationRiskMember
us-gaap:SalesRevenueNetMember CEAD:CustomerThreeMember 2021-01-01
2021-03-31 0001482541 us-gaap:CustomerConcentrationRiskMember
us-gaap:AccountsReceivableMember CEAD:CustomerOneMember 2022-01-01
2022-03-31 0001482541 us-gaap:CustomerConcentrationRiskMember
us-gaap:AccountsReceivableMember CEAD:CustomerTwoMember 2022-01-01
2022-03-31 0001482541 us-gaap:CustomerConcentrationRiskMember
us-gaap:AccountsReceivableMember CEAD:CustomerThreeMember
2022-01-01 2022-03-31 0001482541
us-gaap:CustomerConcentrationRiskMember
us-gaap:AccountsReceivableMember CEAD:CustomerOneMember 2021-01-01
2021-03-31 0001482541 us-gaap:CustomerConcentrationRiskMember
us-gaap:AccountsReceivableMember CEAD:CustomerTwoMember 2021-01-01
2021-03-31 0001482541 CEAD:EquipmentAndSystemsSalesMember
2022-01-01 2022-03-31 0001482541
CEAD:EquipmentAndSystemsSalesMember 2021-01-01 2021-03-31
0001482541 CEAD:EngineeringAndOtherServicesMember 2022-01-01
2022-03-31 0001482541 CEAD:EngineeringAndOtherServicesMember
2021-01-01 2021-03-31 0001482541 us-gaap:ShippingAndHandlingMember
2022-01-01 2022-03-31 0001482541 us-gaap:ShippingAndHandlingMember
2021-01-01 2021-03-31 0001482541 CEAD:TwoThousandAndTwentyTwoMember
2022-03-31 0001482541 us-gaap:CostOfSalesMember 2022-01-01
2022-03-31 0001482541 us-gaap:CostOfSalesMember 2021-01-01
2021-03-31 0001482541 CEAD:AdvertisingAndMarketingExpensesMember
2022-01-01 2022-03-31 0001482541
CEAD:AdvertisingAndMarketingExpensesMember 2021-01-01 2021-03-31
0001482541 CEAD:ProductDevelopmentCostsMember 2022-01-01 2022-03-31
0001482541 CEAD:ProductDevelopmentCostsMember 2021-01-01 2021-03-31
0001482541 us-gaap:SellingGeneralAndAdministrativeExpensesMember
2022-01-01 2022-03-31 0001482541
us-gaap:SellingGeneralAndAdministrativeExpensesMember 2021-01-01
2021-03-31 0001482541 CEAD:NewFacilityLeaseMember 2021-07-28
0001482541 CEAD:NewFacilityLeaseMember 2021-07-24 2021-07-28
0001482541 2021-01-01 2021-12-31 0001482541
us-gaap:FurnitureAndFixturesMember 2022-03-31 0001482541
us-gaap:FurnitureAndFixturesMember 2021-12-31 0001482541
us-gaap:VehiclesMember 2022-03-31 0001482541 us-gaap:VehiclesMember
2021-12-31 0001482541 us-gaap:LeaseholdImprovementsMember
2022-03-31 0001482541 us-gaap:LeaseholdImprovementsMember
2021-12-31 0001482541 us-gaap:CostOfSalesMember
us-gaap:PropertyPlantAndEquipmentMember 2022-01-01 2022-03-31
0001482541 CEAD:InventoryMember
us-gaap:PropertyPlantAndEquipmentMember 2022-01-01 2022-03-31
0001482541 2021-02-10 0001482541 2021-02-09 2021-02-10 0001482541
2021-11-30 0001482541 2021-11-29 2021-11-30 0001482541
us-gaap:OtherExpenseMember 2022-01-01 2022-03-31 0001482541
CEAD:SeriesBRedeemableConvertiblePreferredStockMember 2021-09-28
0001482541 us-gaap:ConvertiblePreferredStockMember 2021-09-28
0001482541 2021-09-26 2021-09-28 0001482541 2021-11-01 2021-11-04
0001482541 us-gaap:SeriesBPreferredStockMember 2022-01-01
2022-03-31 0001482541 us-gaap:SeriesBPreferredStockMember
2021-09-27 2021-09-30 0001482541
us-gaap:SeriesBPreferredStockMember 2021-09-30 0001482541
us-gaap:SeriesBPreferredStockMember 2022-02-14 2022-02-16
0001482541 2022-02-14 2022-02-16 0001482541
us-gaap:CommonStockMember us-gaap:SeriesBPreferredStockMember
2022-02-14 2022-02-16 0001482541 us-gaap:WarrantMember
us-gaap:SeriesBPreferredStockMember 2022-02-14 2022-02-16
0001482541 CEAD:WarrantOneMember CEAD:IndefiniteTermMember
us-gaap:SeriesBPreferredStockMember 2022-02-14 2022-02-16
0001482541 CEAD:WarrantOneMember CEAD:IndefiniteTermMember
us-gaap:SeriesBPreferredStockMember 2022-02-16 0001482541
us-gaap:WarrantMember 2022-02-14 2022-02-16 0001482541
us-gaap:WarrantMember 2022-02-16 0001482541
us-gaap:SeriesBPreferredStockMember 2022-02-16 0001482541
us-gaap:SeriesBPreferredStockMember 2022-02-15 0001482541
us-gaap:SeriesBPreferredStockMember
CEAD:DecreaseInCommonStockConversionPriceMember 2022-02-16
0001482541 CEAD:TwoThousandTwentyOneEquityIncentivePlanMember
2022-01-01 2022-01-03 0001482541
us-gaap:RestrictedStockUnitsRSUMember
CEAD:TwoThousandTwentyOneEquityIncentivePlanMember 2022-01-17
0001482541 us-gaap:RestrictedStockUnitsRSUMember
CEAD:JanuarySeventeernTwoThousandTwentyTwoMember
CEAD:TwoThousandTwentyOneEquityIncentivePlanMember 2022-01-17
0001482541 us-gaap:RestrictedStockUnitsRSUMember
CEAD:TwoThousandTwentyOneEquityIncentivePlanMember
CEAD:JanuarySeventeernTwoThousandTwentyThreeMember 2022-01-17
0001482541 us-gaap:RestrictedStockUnitsRSUMember
CEAD:TwoThousandTwentyOneEquityIncentivePlanMember
CEAD:TwoDirectorsMember 2022-01-12 2022-01-17 0001482541
us-gaap:RestrictedStockUnitsRSUMember
CEAD:TwoThousandTwentyOneEquityIncentivePlanMember 2022-01-12
2022-01-17 0001482541 2021-12-29 0001482541
srt:BoardOfDirectorsChairmanMember 2021-12-31 0001482541
us-gaap:CommonStockMember 2022-02-14 2022-02-15 0001482541
us-gaap:WarrantMember 2022-02-15 0001482541 us-gaap:WarrantMember
CEAD:UnderwritersMember 2022-02-14 2022-02-15 0001482541
us-gaap:WarrantMember CEAD:UnderwritersMember 2022-02-15 0001482541
CEAD:TwoThousandAndSeventeenEquityPlanMember 2022-01-01 2022-03-31
0001482541 CEAD:TwoThousandAndTwentyOneEquityPlanMember 2021-03-22
0001482541 CEAD:TwoThousandTwentyOneEquityIncentivePlanMember
2022-01-01 2022-03-31 0001482541
CEAD:TwoThousandTwentyOneEquityPlanMember CEAD:EmployeesMember
2022-01-01 2022-03-31 0001482541
CEAD:TwoThousandTwentyOneEquityPlanMember CEAD:DirectorsMember
2022-01-01 2022-03-31 0001482541
CEAD:TwoThousandTwentyOneEquityPlanMember 2022-03-31 0001482541
CEAD:TwoThousandTwentyOneEquityPlanMember
CEAD:RestrictedSharesIssuedMember 2022-01-01 2022-03-31 0001482541
CEAD:TwoThousandTwentyOneEquityPlanMember
CEAD:NonQualifiedStockOptionMember 2022-03-31 0001482541
CEAD:TwoThousandTwentyOneEquityPlanMember
CEAD:IncentiveStockOptionMember 2022-03-31 0001482541
CEAD:TwoThousandTwentyOneEquityPlanMember
CEAD:IncentiveStockOptionMember
us-gaap:RestrictedStockUnitsRSUMember 2022-03-31 0001482541
CEAD:EmployeesMember 2022-01-01 2022-03-31 0001482541
CEAD:ThreeNewEmployeesMember 2022-01-01 2022-03-31 0001482541
CEAD:CheifFinancialOfficerMember 2022-01-02 2022-03-30 0001482541
CEAD:OneFormerEmployeeMember 2022-01-01 2022-03-31 0001482541
CEAD:OneFormerEmployeeMember 2022-03-31 0001482541
CEAD:NonQualifiedStockOptionsMember
CEAD:TwoThousandAndSeventeenEquityPlanMember
CEAD:EmployeesAndConsultantsMember 2022-01-01 2022-03-31 0001482541
CEAD:NonQualifiedStockOptionsMember
CEAD:TwoThousandAndSeventeenEquityPlanMember
CEAD:EmployeesAndConsultantsMember 2021-01-01 2021-03-31 0001482541
srt:DirectorMember CEAD:TwoThousandAndSeventeenEquityPlanMember
2022-01-01 2022-03-31 0001482541 srt:DirectorMember
CEAD:TwoThousandAndSeventeenEquityPlanMember 2021-01-01 2021-03-31
0001482541 srt:DirectorMember
CEAD:TwoThousandAndTwentyOnePlanMember
CEAD:NonQualifiedStockOptionsMember 2022-01-02 2022-01-03
0001482541 CEAD:TwoThousandAndTwentyOneEquityPlanMember
CEAD:NonQualifiedStockOptionsMember 2022-01-02 2022-01-03
0001482541 CEAD:DirectorsMember
CEAD:TwoThousandTwentyOneEquityPlanMember
us-gaap:RestrictedStockUnitsRSUMember 2022-01-16 2022-01-17
0001482541 CEAD:DirectorsMember
CEAD:TwoThousandTwentyOneEquityPlanMember CEAD:VestedMember
2022-03-31 0001482541 CEAD:DirectorsMember
CEAD:TwoThousandTwentyOneEquityPlanMember
us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-03-31
0001482541
CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember
CEAD:DirectorsMember 2022-01-01 2022-03-31 0001482541
CEAD:EmployeesAndConsultantsMember
CEAD:NonQualifiedStockOptionsMember
CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember
2021-12-31 0001482541 CEAD:EmployeesAndConsultantsMember
CEAD:NonQualifiedStockOptionsMember
CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember
2022-01-01 2022-03-31 0001482541 CEAD:EmployeesAndConsultantsMember
CEAD:NonQualifiedStockOptionsMember
CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember
2022-03-31 0001482541 CEAD:DirectorsMember
CEAD:NonQualifiedStockOptionsMember
CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember
2021-12-31 0001482541 CEAD:DirectorsMember
CEAD:NonQualifiedStockOptionsMember
CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember
2022-01-01 2022-03-31 0001482541
CEAD:NonQualifiedStockOptionsMember
CEAD:TwoThousandAndSeventeenEquityPlanMember CEAD:DirectorsMember
2020-01-01 2020-12-31 0001482541 CEAD:DirectorsMember
CEAD:NonQualifiedStockOptionsMember
CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember
2022-03-31 0001482541
CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember
CEAD:EmployeesAndConsultantsMember 2021-12-31 0001482541
CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember
CEAD:EmployeesAndConsultantsMember 2022-01-01 2022-03-31 0001482541
CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember
CEAD:EmployeesAndConsultantsMember 2022-03-31 0001482541
CEAD:DirectorsMember
CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember
2021-12-31 0001482541 CEAD:DirectorsMember
CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember
2022-03-31 0001482541 CEAD:TwoThousandAndSeventeenEquityPlanMember
CEAD:EmployeesDirectorsandConsultantsMember
us-gaap:RestrictedStockUnitsRSUMember 2021-12-31 0001482541
CEAD:TwoThousandAndSeventeenEquityPlanMember
CEAD:EmployeesDirectorsandConsultantsMember
us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-03-31
0001482541 CEAD:TwoThousandAndSeventeenEquityPlanMember
CEAD:EmployeesDirectorsandConsultantsMember
us-gaap:RestrictedStockUnitsRSUMember 2022-03-31 0001482541
CEAD:WarrantsRangeMember 2022-03-31 0001482541
CEAD:WarrantsRangeMember 2022-01-01 2022-03-31 0001482541
CEAD:WarrantsRangeOneMember 2022-03-31 0001482541
CEAD:WarrantsRangeOneMember 2022-01-01 2022-03-31 0001482541
CEAD:WarrantsRangeTwoMember 2022-03-31 0001482541
CEAD:WarrantsRangeTwoMember 2022-01-01 2022-03-31 0001482541
CEAD:WarrantsRangeThreeMember 2022-03-31 0001482541
CEAD:WarrantsRangeThreeMember 2022-01-01 2022-03-31 0001482541
CEAD:WarrantsRangeFourMember 2022-03-31 0001482541
CEAD:WarrantsRangeFourMember 2022-01-01 2022-03-31 0001482541
us-gaap:SeriesBPreferredStockMember
CEAD:SecuritiesPurchaseAgreementMember 2021-09-26 2021-09-28
0001482541 us-gaap:SeriesBPreferredStockMember
CEAD:SecuritiesPurchaseAgreementMember 2021-09-28 0001482541
us-gaap:SeriesBPreferredStockMember
CEAD:SecuritiesPurchaseAgreementMember srt:MaximumMember 2021-09-28
0001482541 us-gaap:SeriesBPreferredStockMember
CEAD:SecuritiesPurchaseAgreementMember 2021-09-27 2021-09-28
0001482541 us-gaap:PrivatePlacementMember
CEAD:PlacementAgentWarrantsMember 2021-09-28 0001482541
CEAD:TwoThousandTwentyTwoInvestorWarrantsMember 2022-02-15
0001482541 CEAD:TwoThousandTwentyTwoInvestorWarrantsMember
2022-02-13 2022-02-15 0001482541
CEAD:TwoThousandTwentyTwoOverAllotmentWarrantsMember 2022-02-15
0001482541 CEAD:TwoThousandTwentyTwoOverAllotmentWarrantsMember
2022-02-13 2022-02-15 0001482541
CEAD:TwoThousandTwentyTwoOverAllotmentWarrantsMember 2022-02-10
2022-02-15 0001482541
CEAD:TwoThousandTwentyTwoUnderwriterWarrantsMember 2022-02-15
0001482541 CEAD:TwoThousandTwentyTwoUnderwriterWarrantsMember
2022-02-13 2022-02-15 0001482541
us-gaap:SeriesBPreferredStockMember 2022-02-12 2022-02-16
0001482541 us-gaap:CommonStockMember 2022-02-12 2022-02-16
0001482541
CEAD:SeriesBPreferredSharesPreFundedConversionWarrantsMember
2022-02-12 2022-02-16 0001482541
CEAD:SeriesBPreferredSharesPreFundedConversionWarrantsMember
2022-02-16 0001482541
CEAD:SeriesBPreferredSharesConversionWarrantsMember 2022-02-12
2022-02-16 0001482541
CEAD:SeriesBPreferredSharesConversionWarrantsMember 2022-02-16
0001482541 CEAD:SeriesBPreferredSharesConversionWarrantsMember
2022-02-15 0001482541 CEAD:ConsultingAgreementMember 2022-01-01
2022-03-31 0001482541 us-gaap:SubsequentEventMember
CEAD:TwentyOneEmployeesMember CEAD:EmploymentAgreementMember
2022-03-29 2022-04-01 0001482541 us-gaap:SubsequentEventMember
CEAD:EmploymentAgreementMember 2022-03-29 2022-04-01 0001482541
us-gaap:SubsequentEventMember CEAD:EmploymentAgreementMember
2022-04-01 iso4217:USD xbrli:shares iso4217:USD xbrli:shares
utr:sqft xbrli:pure
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
10-Q
☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
FOR
THE QUARTERLY PERIOD ENDED
MARCH 31, 2022
OR
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Commission
File Number:
000-54286
CEA INDUSTRIES INC.
(formerly
known as Surna Inc.)
(Exact
name of registrant as specified in its charter)
Nevada |
|
27-3911608 |
(State
or other jurisdiction of
incorporation
or organization)
|
|
(I.R.S.
Employer
Identification
No.)
|
385 South Pierce Avenue,
Suite C
Louisville,
Colorado
80027
|
|
80027 |
(Address
of principal executive offices) |
|
(Zip
code) |
(303)
993-5271
(Registrant’s
telephone number, including area code)
Securities
registered pursuant to Section 12(b) of the Exchange
Act:
Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on which registered |
Common Stock, $0.00001 par value |
|
CEAD |
|
Nasdaq Capital Markets |
Warrants to purchase common stock |
|
CEADW |
|
Nasdaq Capital Markets |
Securities
registered pursuant to Section 12(g) of the Act:
None
Indicate
by check mark whether the issuer (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Exchange Act during the
preceding 12 months (or for such shorter period that the registrant
was required to file such reports), and (2) has been subject to
such filing requirements for the last 90 days.
YES ☒ NO
☐
Indicate
by check mark whether the registrant has submitted electronically
every Interactive Data File required to be submitted pursuant to
Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the
preceding 12 months (or for such shorter period that the registrant
was required to submit such files).
YES ☒ NO
☐
Indicate
by check mark whether the registrant is a large accelerated filer,
an accelerated filer, a non-accelerated filer, a smaller reporting
company, or an emerging growth company. See the definitions of
“large accelerated filer, “accelerated filer,” “non-accelerated
filer,” “smaller reporting company,” and “emerging growth company”
in Rule 12b-2 of the Exchange Act.
Large
Accelerated Filer |
☐ |
Accelerated
Filer |
☐ |
Non-accelerated Filer |
☒ |
Smaller
Reporting Company |
☒ |
|
|
Emerging
Growth Company |
☐ |
If an
emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided
pursuant to Section 13(a) of the Exchange Act. ☐
Indicate
by check mark whether the registrant is a shell company (as defined
in Rule 12b-2 of the Exchange Act). YES ☐
NO ☒
As of
May 12, 2022, the number of outstanding shares of common stock of
the registrant was
7,784,444.
CEA
Industries Inc.
Quarterly
Report on Form 10-Q
For
the Quarterly Period Ended March 31, 2022
Table
of Contents
In this Quarterly Report on Form 10-Q, unless otherwise indicated,
the “Company”, “we”, “us” or “our” refer to CEA Industries Inc.
and, where appropriate, its wholly owned
subsidiary.
CAUTIONARY STATEMENT
This
Quarterly Report on Form 10-Q, including “Management’s Discussion
and Analysis of Financial Condition and Results of Operations” in
Item 2, contains forward-looking statements that involve
substantial risks and uncertainties. These forward-looking
statements are not historical fact but are based on current
management expectations that involve substantial risks,
uncertainties, and other factors, some of which are beyond our
control and difficult to predict and could cause actual results to
differ materially from those expressed in, or implied by, these
forward-looking statements. Forward-looking statements relate to
future events or our future financial performance. We generally
identify forward-looking statements by terminology such as “may,”
“will,” “should,” “expects,” “plans,” “anticipates,” “could,”
“intends,” “target,” “projects,” “contemplates,” “believes,”
“estimates,” “predicts,” “potential,” or “continue” or the negative
of these terms or other similar words. All statements, other than
statements of historical fact, are statements that could be deemed
forward-looking statements including, but not limited to, any
projections of revenue, gross profit, earnings or loss, tax
provisions, cash flows or other financial items; any statements of
the plans, strategies or objectives of management for future
operations; any statements regarding current or future
macroeconomic or industry-specific trends or events and the impact
of those trends and events on us or our financial performance; any
statements regarding pending investigations, legal claims or tax
disputes; any statements of expectation or belief; and any
statements of assumptions underlying any of the
foregoing.
These
forward-looking statements are subject to known and unknown risks,
uncertainties, assumptions and other factors that could cause our
actual results of operations, financial condition, liquidity,
performance, prospects, opportunities, achievements or industry
results, as well as those of the markets we serve or intend to
serve, to differ materially from those expressed in, or suggested
by, these forward-looking statements. These forward-looking
statements are based on assumptions regarding our present and
future business strategies and the environment in which we operate.
Important factors that could cause those differences include, but
are not limited to:
|
● |
our
business prospects and the prospects of our existing and
prospective customers; |
|
|
|
|
● |
the
impact on our business and that of our customers of the current and
future response by the government and business to the COVID-19
pandemic, including what is necessary to protect our staff and the
staff of our customers in the conduct of our business; |
|
|
|
|
● |
our
overall financial condition, including our reduced revenue and
business disruption, due to the COVID-19 pandemic business and
economic response and its consequences; |
|
|
|
|
● |
the
inherent uncertainty of product development; |
|
|
|
|
● |
regulatory,
legislative and judicial developments, especially those related to
changes in, and the enforcement of, cannabis laws; |
|
|
|
|
● |
increasing
competitive pressures in the CEA (Controlled Environment
Agriculture) industry; |
|
|
|
|
● |
the
ability to effectively operate our business, including servicing
our existing customers and obtaining new business; |
|
|
|
|
● |
our
relationships with our customers and suppliers; |
|
|
|
|
● |
the
continuation of normal payment terms and conditions with our
customers and suppliers, including our ability to obtain advance
payments from our customers; |
|
|
|
|
● |
general
economic conditions, our customers’ operations and access to
capital, and market and business disruptions including severe
weather conditions, natural disasters, health hazards, terrorist
activities, financial crises, political crises or other major
events, or the prospect of these events, adversely affecting demand
for the products and services offered by us in the markets in which
we operate; |
|
● |
the
continuation of normal supply of products from our
suppliers; |
|
|
|
|
● |
changes
in our business strategy or development plans, including our
expected level of capital expenses and working capital; |
|
|
|
|
● |
our
ability to attract and retain qualified personnel; |
|
|
|
|
● |
our
ability to raise equity and debt capital, as needed from time to
time, to fund our operations and growth strategy, including
possible acquisitions; |
|
|
|
|
● |
our
ability to identify, complete and integrate potential strategic
acquisitions; |
|
|
|
|
● |
future
revenue being lower than expected; |
|
|
|
|
● |
our
ability to convert our backlog into revenue in a timely manner, or
at all; and |
|
|
|
|
● |
our
intention not to pay dividends. |
Although
we believe that we use reasonable assumptions for these
forward-looking statements, any of those assumptions could prove to
be inaccurate, and as a result, the forward-looking statements
based on those assumptions also could be inaccurate. In light of
these and other uncertainties, the inclusion of a projection or
forward-looking statement in this Quarterly Report on Form 10-Q
should not be regarded as a representation by us that our plans and
objectives will be achieved. These risks and uncertainties include
those described or identified in “Item 1A – Risk Factors” in our
Annual Report on Form 10-K for the year ended December 31, 2021, as
updated from time to time in the Company’s filings with the U.S.
Securities and Exchange Commission (the “SEC”). You should not
place undue reliance on these forward-looking statements, which
apply only as of the date of this Quarterly Report on Form 10-Q.
Except as required by the federal securities laws, we undertake no
obligation to revise or update any forward-looking statements,
whether as a result of new information, future events or otherwise,
to reflect events or circumstances occurring after the date of this
Quarterly Report on Form 10-Q. The forward-looking statements and
projections contained in this Quarterly Report on Form 10-Q are
intended to be within the meaning of “forward-looking statements”
in Section 27A of the Securities Act of 1933, as amended (the
“Securities Act”).
PART I — FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
CEA
Industries Inc.
Condensed Consolidated Balance Sheets
(in US Dollars except share numbers)
The
accompanying notes are an integral part of these condensed
consolidated financial statements.
CEA Industries Inc.
Condensed
Consolidated Statements of Operations
(in US Dollars except share numbers)
(Unaudited)
The
accompanying notes are an integral part of these condensed
consolidated financial statements.
CEA Industries Inc.
Condensed
Consolidated Statements of Changes in Shareholders’ Equity
(Deficit)
For
the Three Months Ended March 31, 2022 and 2021
(in US Dollars except share numbers)
(Unaudited)
|
|
Number
of
Shares
|
|
|
Amount |
|
|
Number of
Shares
|
|
|
Amount |
|
|
Number of
Shares
to
be
Issued
|
|
|
Amount |
|
|
Additional
Paid
in
Capital
|
|
|
Accumulated
Deficit
|
|
|
Shareholders’
Deficit
|
|
|
|
Series
A
Preferred
Stock
|
|
|
Common
Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Number
of
Shares
|
|
|
Amount |
|
|
Number of
Shares
|
|
|
Amount |
|
|
Number of
Shares
to
be
Issued
|
|
|
Amount |
|
|
Additional
Paid
in
Capital
|
|
|
Accumulated
Deficit
|
|
|
Shareholders’
Deficit
|
|
Balance
December 31, 2020 |
|
|
42,030,331 |
|
|
$ |
420 |
|
|
|
1,576,844 |
|
|
$ |
16 |
|
|
|
- |
|
|
|
|
|
|
$ |
26,107,159 |
|
|
$ |
(27,443,643 |
) |
|
$ |
(1,336,048 |
) |
Balance |
|
|
42,030,331 |
|
|
$ |
420 |
|
|
|
1,576,844 |
|
|
$ |
16 |
|
|
|
- |
|
|
|
|
|
|
$ |
26,107,159 |
|
|
$ |
(27,443,643 |
) |
|
$ |
(1,336,048 |
) |
Common
shares to be issued in settlement of legal dispute |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
6,667 |
|
|
|
67,000 |
|
|
|
- |
|
|
|
- |
|
|
|
67,000 |
|
Fair
value of vested stock options granted to employees |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
128,434 |
|
|
|
- |
|
|
|
128,434 |
|
Fair
value of vested stock options granted to directors |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
6,342 |
|
|
|
- |
|
|
|
6,342 |
|
Net
loss |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(793,368 |
) |
|
|
(793,368 |
) |
Balance
March 1, 2021 |
|
|
42,030,331 |
|
|
$ |
420 |
|
|
|
1,576,844 |
|
|
$ |
16 |
|
|
|
6,667 |
|
|
$ |
67,000 |
|
|
$ |
26,241,935 |
|
|
$ |
(28,237,011 |
) |
|
$ |
(1,927,640 |
) |
Balance |
|
|
42,030,331 |
|
|
$ |
420 |
|
|
|
1,576,844 |
|
|
$ |
16 |
|
|
|
6,667 |
|
|
$ |
67,000 |
|
|
$ |
26,241,935 |
|
|
$ |
(28,237,011 |
) |
|
$ |
(1,927,640 |
) |
The
accompanying notes are an integral part of these condensed
consolidated financial statements.
CEA Industries Inc.
Condensed
Consolidated Statements of Cash Flows
(in US Dollars except share numbers)
(Unaudited)
The
accompanying notes are an integral part of these condensed
consolidated financial statements.
CEA Industries Inc.
Notes
to Condensed Consolidated Financial Statements
March
31, 2022
(in US Dollars except share numbers)
(Unaudited)
Note
1 – General
Description of Business
CEA
Industries Inc., formerly Surna Inc. (the “Company”), was
incorporated in Nevada on October 15, 2009. We design, engineer and
sell environmental control and other technologies for the
Controlled Environment Agriculture (“CEA”) industry. The CEA
industry is one of the fastest-growing sectors of the United
States’ economy. From leafy greens (kale, Swiss chard, mustard,
cress), microgreens (leafy greens harvested at the first true leaf
stage), ethnic vegetables, ornamentals, and small fruits (such as
strawberries, blackberries and raspberries) to bell peppers,
cucumbers, tomatoes and cannabis and hemp, some producers grow
crops indoors in response to market dynamics or as part of their
preferred farming practice. In service of the CEA industry, our
principal technologies include: (i) architectural design and
licensed engineering of commercial scale thermodynamic systems
specific to cultivation facilities, (ii) liquid-based process
cooling systems and other climate control systems, (iii) air
handling equipment and systems, (iv) LED lighting, benching and
racking solutions for indoor cultivation, (v) automation and
control devices, systems and technologies used for environmental,
lighting and climate control, and (vi) preventive maintenance
services for CEA facilities Our customers include commercial,
state- and provincial-regulated CEA growers in the U.S. and Canada
as well as other international locations. Customers are those
growers building new facilities and those expanding or retrofitting
existing facilities. Currently, our revenue stream is derived
primarily from supplying our products, services and technologies to
commercial indoor facilities ranging from several thousand to more
than 100,000 square feet. Headquartered in Louisville, Colorado, we
leverage our experience in this space to bring value-added climate
control solutions to our customers that help improve their overall
crop quality and yield, optimize energy and water efficiency, and
satisfy the evolving state and local codes, permitting and
regulatory requirements. Although our customers do, we neither
produce nor sell cannabis or its related products.
Impact of the COVID-19
Pandemic on Our Business
The
impact of the government and the business economic response to the
COVID-19 pandemic has affected demand across the majority of our
markets and disrupted work on projects. The COVID-19 pandemic is
expected to have continued adverse effects on our sales, project
implementation, supply chain infrastructure, operating margins, and
working capital.
The
resulting effects and uncertainties from the COVID-19 pandemic,
including the depth and duration of the disruptions to customers
and suppliers, its future effect on our business, on our results of
operations, and on our financial condition, cannot be predicted. We
expect that the economic disruptions will continue to have an
effect on our business over the longer term. Despite this
uncertainty, we continue to monitor costs and continue to take
actions to reduce costs in order to mitigate the impact of the
COVID-19 pandemic to the best of our ability. However, these
actions may not be sufficient in the long run to avoid reduced
sales, increased losses and reduced operating cash flows in our
business. During the three months ended March 31, 2022, the Company
experienced significant delays in the receipt of equipment it had
ordered to meet its customer orders due to disruption and delays in
its supply chain arising from the long-term effects of the COVID-19
pandemic. Consequently, our revenue recognition of these customer
sales has been delayed until future periods when the shipment of
these orders can be completed.
Financial Statement
Presentation
The preparation of the consolidated financial statements in
conformity with accounting principles generally accepted in the
United States of America (“GAAP”) requires management to make
estimates and assumptions that affect reported amounts and related
disclosures.
The accompanying consolidated financial statements have been
prepared on a going concern basis, which contemplates the
realization of assets and the satisfaction of liabilities in the
normal course of business within one year after the date the
consolidated financial statements are available to be issued. The
Company continues to experience recurring losses since its
inception. As a result, in order to continue as a going concern,
the Company has been reliant on the ability to obtain additional
sources of financing to fund growth. As indicated in Note 9 –
Shareholders Equity (Deficit) below, on February 15, 2022, the
Company received approximately $22,000,000 in
proceeds from completion of an equity offering. Based on
management’s evaluation, the proceeds from the Offering will be
more than sufficient to fund any deficiencies in working capital or
cash flow from operations, and the Company is confident that it
will be able to meet its obligations as they come due, and fund
operations for at least 12 months after the date the consolidated
financial statements are available to be issued. Accordingly, the
conditions around liquidity and limited working capital necessary
to fund operations have been addressed.
Interim Financial Statements
The
accompanying unaudited condensed consolidated financial statements
of the Company have been prepared in conformity with accounting
principles generally accepted in the United States of America
(“GAAP”) for interim financial information and with the
instructions to Form 10-Q and Rule 10-01 of Regulation S-X.
Pursuant to these rules and regulations, certain information and
note disclosures, normally included in financial statements
prepared in accordance with GAAP, have been condensed or omitted.
In the opinion of management, all adjustments (consisting of normal
recurring items) considered necessary for a fair presentation have
been included. Operating results for the three months ended March
31, 2022 are not necessarily indicative of the results that may be
expected for the fiscal year ending December 31, 2022. The balance
sheet as of December 31, 2021 has been derived from the audited
financial statements at that date but does not include all the
information and footnotes required by GAAP for complete financial
statements. For further information, refer to the consolidated
financial statements and notes thereto contained in the Annual
Report on Form 10-K for the year ended December 31,
2021.
CEA
Industries Inc.
Notes
to Condensed Consolidated Financial Statements
March
31, 2022
(in US Dollars except share numbers)
(Unaudited)
Principles
of Consolidation
The
condensed consolidated financial statements include the accounts of
the Company and its controlled and wholly owned subsidiaries, Hydro
Innovations, LLC (“Hydro”) and Surna Cultivation Technologies LLC
(“SCT”). Intercompany transactions, profit, and balances are
eliminated in consolidation.
Reverse Stock
Split
On January 17, 2022, the
Company’s Board of Directors approved a reverse stock split at a
ratio of one-for-one hundred and fifty. Such reverse stock split
was implemented effective January 27, 2022. The par value
for the Common Stock was not affected.
As a
result of this reverse stock split, the number of the Company’s
shares of common stock issued and outstanding as of December 31,
2021, was reduced from
240,125,224 to 1,600,835.
All
Common Stock, warrants, options and per share amounts set forth
herein are presented to give retroactive effect to the Reverse
Split for all periods presented.
Use of
Estimates
Management
makes estimates and assumptions that affect the reported amounts of
assets and liabilities and the disclosure of contingent assets and
liabilities at the date of the financial statements and that affect
the reported amounts of revenue and expenses during the reporting
period. The Company bases its estimates on historical experience
and on various other assumptions that it believes to be reasonable
under the circumstances, the results of which form the basis for
making judgments about the carrying values of assets and
liabilities that are not readily apparent from other sources.
Actual results could differ from those estimates. Key estimates
include: allocation of transaction prices to performance
obligations under contracts with customers, standalone selling
prices, timing of expected revenue recognition on remaining
performance obligations under contracts with customers, valuation
of intangible assets, valuation of equity-based compensation,
valuation of deferred tax assets and liabilities, warranty
accruals, accounts receivable and inventory allowances, and legal
contingencies.
Cash, Cash Equivalents
and Restricted Cash
All highly liquid investments with original maturities of three
months or less at the date of purchase are considered to be cash
equivalents. The Company may, from time to time, have deposits in
financial institutions that exceed the federally insured amount of
$250,000. As of March 31,
2022, the balance in the Company’s account was approximately
$22,034,000, consequently
$21,784,000
of this balance was not insured by the FDIC. The Company has not
experienced any losses to date on depository accounts.
Income (Loss) Per
Common Share
Basic
income (loss) per common share is computed by dividing net income
(loss) attributable to common stockholders by the weighted-average
number of common shares outstanding during the period without
consideration of common stock equivalents. Diluted net income
(loss) per common share is computed by dividing net income (loss)
by the weighted-average number of common shares outstanding and
potentially dilutive common stock equivalents, including stock
options, warrants and restricted stock units and other equity-based
awards, except in cases where the effect of the common stock
equivalents would be antidilutive. Potential common stock
equivalents consist of common stock issuable upon exercise of stock
options and warrants and the vesting of restricted stock units
using the treasury method.
During
the three months ended March 31, 2022 and 2021, there were warrants
and options outstanding to purchase Company common stock and shares
of convertible preferred stock and restricted stock units that were
convertible into shares of the Company’s common stock. During the
three-month period ended March 31, 2022, the Company incurred a net
loss and consequently the common share equivalents of these
potentially dilutive equity instruments have not been included in
the calculations of loss per share because such inclusion would
have been anti-dilutive.
CEA
Industries Inc.
Notes
to Condensed Consolidated Financial Statements
March
31, 2022
(in US Dollars except share numbers)
(Unaudited)
As of
March 31, 2022, and 2021, there were respectively,
8,021,057 and
201,662, potentially dilutive equity instruments outstanding
in respect of shares of convertible preferred stock and warrants
and options outstanding to purchase Company common
stock.
Goodwill
The
Company recorded goodwill in connection with its acquisition of
Hydro Innovations, LLC in July 2014. Goodwill is reviewed for
impairment annually or more frequently when events or changes in
circumstances indicate that fair value of the reporting unit has
been reduced to less than its carrying value. The Company performs
a quantitative impairment test annually on December 31 by comparing
the fair value of the reporting unit with its carrying amount,
including goodwill. If the fair value of the reporting unit exceeds
its carrying amount, goodwill is considered not impaired. An
impairment charge would be recognized for the amount by which the
carrying amount exceeds the reporting unit’s fair value. The
Company determined that it has one reporting unit.
During
the three months ended March 31, 2022, the Company concluded that
the projected impact of the COVID-19 pandemic on its sales,
contract completion and revenues in the near term, together with
the volatility in its share price during the quarter represented
potential indicators of impairment. Accordingly, the Company
performed an interim impairment analysis at March 31, 2022 and
concluded that no impairment relating to goodwill existed at March
31, 2022.
Temporary
Equity
Shares
of preferred stock that are redeemable for cash or other assets are
classified as temporary equity if they are redeemable, at the
option of the holder, at a fixed or determinable price on a fixed
or determinable date or upon the occurrence of an event that is not
solely within the control of the issuer. Redeemable equity
instruments are initially carried at the fair value of the equity
instrument at the issuance date, net of issuance costs, which is
subsequently adjusted to redemption value (including the amount for
dividends earned but not yet declared or paid) at each balance
sheet date if the instrument is currently redeemable or if it is
probable that the instrument will become redeemable.
CEA
Industries Inc.
Notes
to Condensed Consolidated Financial Statements
March
31, 2022
(in US Dollars except share numbers)
(Unaudited)
Revenue
Recognition
On January 1, 2018, the Company adopted Accounting Standards Update
(“ASU”) 2014-09 (Topic 606), Revenue from Contracts with
Customers and all the related amendments (“ASC 606” or the
“revenue standard”) to all contracts and elected the modified
retrospective method.
The following table sets forth the Company’s revenue by source:
Schedule of Revenue by
Source
|
|
2022 |
|
|
2021 |
|
|
|
For the Three Months
Ended
March 31,
|
|
|
|
2022 |
|
|
2021 |
|
Equipment and systems sales |
|
$ |
1,642,572 |
|
|
$ |
2,163,468 |
|
Engineering and other services |
|
|
86,049 |
|
|
|
181,083 |
|
Shipping and handling |
|
|
15,806 |
|
|
|
21,978 |
|
Total
revenue |
|
$ |
1,744,427 |
|
|
$ |
2,366,529 |
|
Revenue Recognition
Accounting Policy Summary
The Company accounts for revenue in accordance with ASC 606. Under
the revenue standard, a performance obligation is a promise in a
contract with a customer to transfer a distinct good or service to
the customer. Most of the Company’s contracts contain multiple
performance obligations that include engineering and technical
services as well as the delivery of a diverse range of climate
control system equipment and components, which can span multiple
phases of a customer’s project life cycle from facility design and
construction to equipment delivery and system installation and
start-up. The Company does not provide construction services or
system installation services. Some of the Company’s contracts with
customers contain a single performance obligation, typically
engineering only services contracts.
A
contract’s transaction price is allocated to each distinct
performance obligation and recognized as revenue when, or as, the
performance obligation is satisfied. When there are multiple
performance obligations within a contract, the Company allocates
the transaction price to each performance obligation based on
standalone selling price. When estimating the selling price, the
Company uses various observable inputs. The best observable input
is the Company’s actual selling price for the same good or service,
however, this input is generally not available for the Company’s
contracts containing multiple performance obligations. For
engineering services, the Company estimates the standalone selling
price by reference to certain physical characteristics of the
project, such as facility size and mechanical systems involved,
which are indicative of the scope and complexity of the mechanical
engineering services to be provided. For equipment sales, the
standalone selling price is determined by forecasting the expected
costs of the equipment and components and then adding an
appropriate margin, based on a range of acceptable margins
established by management. Depending on the nature of the
performance obligations, the Company may use a combination of
different methods and observable inputs if certain performance
obligations have highly variable or uncertain standalone selling
prices. Once the selling prices are determined, the Company applies
the relative values to the total contract consideration and
estimates the amount of the transaction price to be recognized as
each promise is fulfilled.
Generally,
satisfaction occurs when control of the promised goods is
transferred to the customer or as services are rendered or
completed in exchange for consideration in an amount for which the
Company expects to be entitled.The
Company recognizes revenue for the sale of goods when control
transfers to the customer, which primarily occurs at the time of
shipment. The Company’s historical rates of return are
insignificant as a percentage of sales and, as a result, the
Company does not record a reserve for returns at the time the
Company recognizes revenue. The Company has elected to exclude from
the measurement of the transaction price all taxes (e.g., sales,
use, value added, and certain excise taxes) that are assessed by a
governmental authority in connection with a specific
revenue-producing transaction and collected by the Company from the
customer. Accordingly, the Company recognizes revenue net of sales
taxes. The revenue and cost for freight and shipping is recorded
when control over the sale of goods passes to the Company’s
customers.
The
Company also has performance obligations to perform certain
engineering services that are satisfied over a period of time.
Revenue is recognized from this type of performance obligation as
services are rendered based on the percentage completion towards
certain specified milestones.
The
Company offers assurance-type warranties for its products and
products manufactured by others to meet specifications defined by
the contracts with customers and does not have any material
separate performance obligations related to these warranties. The
Company maintains a warranty reserve based on historical warranty
costs.
Other Judgments and
Assumptions
The Company typically receives customer payments in advance of its
performance of services or transfers of goods. Applying the
practical expedient in ASC 606-10-32-18, which the Company has
elected, the Company does not adjust the promised amount of
consideration for the effects of a significant financing component
since the Company expects, at contract inception, that the period
between when the Company transfers a promised good or service to a
customer and when the customer pays for that good or service will
be one year or less. Accordingly, the remaining performance
obligations related to customer contracts does not consider the
effects of the time value of money.
CEA
Industries Inc.
Notes
to Condensed Consolidated Financial Statements
March
31, 2022
(in US Dollars except share numbers)
(Unaudited)
Applying
the practical expedient in ASC 340-40-25-4, the Company recognizes
the incremental costs of obtaining contracts as an expense when
incurred since the amortization period of the assets that the
Company otherwise would have recognized is one year or less. These
costs include certain sales commissions and incentives, which are
included in selling, general and administrative expenses, and are
payable only when associated revenue has been collected and earned
by the Company.
Contract Assets and
Contract Liabilities
Contract
assets reflect revenue recognized and performance obligations
satisfied in advance of customer billing. Contract liabilities
relate to payments received in advance of the satisfaction of
performance under the contract. The Company receives
payments from customers based on the terms established in its
contracts.
Contract
assets include unbilled amounts where revenue recognized exceeds
the amount billed to the customer and the right of payment is
conditional, subject to completing a milestone, such as a phase of
a project. The Company typicallydoes
not have material amounts of contract assets since revenue is
recognized as control of goods are transferred or as services are
performed. As of March 31, 2022, and 2021, the Company had no
contract assets.
Contract
liabilities consist of advance payments in excess of revenue
recognized. The Company’s contract liabilities are recorded as a
current liability in deferred revenue in the consolidated balance
sheets since the timing of when the Company expects to recognize
revenue is generally less than one year. As of March 31, 2022, and
December 31, 2021, deferred revenue, which was classified as a
current liability, was $5,485,416
and $2,839,838,
respectively.
For
the three months ended March 31, 2022, the Company recognized
revenue of $1,162,374 related to the deferred
revenue at January 1, 2022. For the three months ended March 31,
2021, the Company recognized revenue of $1,880,634 related to the deferred
revenue at January 1, 2021.
Remaining Performance Obligations
Remaining
performance obligations, or backlog, represents the aggregate
amount of the transaction price allocated to the remaining
obligations that the Company has not performed under its customer
contracts. The Company has elected not to use the optional
exemption in ASC 606-10-50-14, which exempts an entity from such
disclosures if a performance obligation is part of a contract with
an original expected duration of one year or less. Accordingly, the
information disclosed about remaining performance obligations
includes all customer contracts, including those with an expected
duration of one year or less.
Industry
uncertainty, project financing concerns, and the licensing and
qualification of our prospective customers, which are out of the
Company’s control, make it difficult for the Company to predict
when it will recognize revenue on its remaining performance
obligations. There are risks that the Company may not realize the
full contract value on customer projects in a timely manner or at
all, and completion of a customer’s cultivation facility project is
dependent upon the customer’s ability to secure funding and real
estate, obtain a license and then build their cultivation facility
so they can take possession of the equipment. Accordingly, the time
it takes for customers to complete a project, which corresponds to
when the Company is able to recognize revenue, is driven by
numerous factors including: (i) the large number of first-time
participants interested in the indoor cannabis cultivation
business; (ii) the complexities and uncertainties involved in
obtaining state and local licensure and permitting; (iii) local and
state government delays in approving licenses and permits due to
lack of staff or the large number of pending applications,
especially in states where there is no cap on the number of
cultivators; (iv) the customer’s need to obtain cultivation
facility financing; (v) the time needed, and coordination required,
for our customers to acquire real estate and properly design and
build the facility (to the stage when climate control systems can
be installed); (vi) the large price tag and technical complexities
of the climate control and air sanitation system; (vii) the
availability of power; and (viii) delays that are typical in
completing any construction project. Further, based on the current
economic climate, the uncertainty regarding the COVID-19 virus, and
the Company’s recent cost cutting measures, there is no assurance
that the Company will be able to fulfill its backlog, and the
Company may experience contract cancellations, project scope
reductions and project delays.
As of
March 31, 2022, the Company’s remaining performance obligations, or
backlog, was $11,179,000.There
is significant uncertainty regarding the timing of the Company’s
recognition of revenue on its remaining performance obligations,
and there is no certainty that these will result in actual
revenues. The backlog at March 31, 2022, includes booked sales
orders of $2,217,000
from
several customers that the Company does not expect to be realized
until 2023, if at all. Given the present economic uncertainty
arising from the impact of the novel coronavirus COVID-19, the
Company believes that several of its current contracts may be
delayed or canceled.
CEA
Industries Inc.
Notes
to Condensed Consolidated Financial Statements
March
31, 2022
(in US Dollars except share numbers)
(Unaudited)
The
remaining performance obligations expected to be recognized through
2023 are as follows:
Schedule of Remaining Performance Obligations Expected to be
Recognized
|
|
2022 |
|
|
2023 |
|
|
Total |
|
Remaining performance obligations
related to engineering only paid contracts |
|
$ |
- |
|
|
$ |
- |
|
|
$ |
- |
|
Remaining performance obligations related to partial equipment paid
contracts |
|
|
8,962,000 |
|
|
|
2,217,000 |
|
|
|
11,179,000 |
|
Total remaining
performance obligations |
|
$ |
8,962,000 |
|
|
$ |
2,217,000 |
|
|
$ |
11,179,000 |
|
Product Warranty
The
Company warrants the products that it manufactures for a warranty
period equal to the lesser of 12 months from start-up or 18 months
from shipment. The Company’s warranty provides for the repair,
rework, or replacement of products (at the Company’s option) that
fail to perform within stated specification. The Company’s
third-party suppliers also warrant their products under similar
terms, which are passed through to the Company’s
customers.
The
Company assesses the historical warranty claims on its manufactured
products and, since 2016, warranty claims have been approximately
1% of annual revenue generated on these products. Based on the
Company’s warranty policy, an accrual is established at 1% of the
trailing 18 months revenue. The Company continues to assess the
need to record a warranty reserve at the time of sale based on
historical claims and other factors. As of March 31, 2022, and
December 31, 2021, the Company had an accrued warranty reserve
amount of $187,702
and $186,605,
respectively, which are included in accounts payable and accrued
liabilities on the Company’s consolidated balance
sheets.
Accounting for
Share-Based Compensation
The
Company recognizes the cost resulting from all share-based
compensation arrangements, including stock options, restricted
stock awards and restricted stock units that the Company grants
under its equity incentive plan in its condensed consolidated
financial statements based on their grant date fair value. The
expense is recognized over the requisite service period or
performance period of the award. Awards with a graded vesting
period based on service are expensed on a straight-line basis for
the entire award. Awards with performance-based vesting conditions,
which require the achievement of a specific company financial
performance goal at the end of the performance period and required
service period, are recognized over the performance period. Each
reporting period, the Company reassesses the probability of
achieving the respective performance goal. If the goals are not
expected to be met, no compensation cost is recognized and any
previously recognized amount recorded is reversed. If the award
contains market-based vesting conditions, the compensation cost is
based on the grant date fair value and expected achievement of
market condition and is not subsequently reversed if it is later
determined that the condition is not likely to be met or is
expected to be lower than initially expected.
The
grant date fair value of stock options is based on the
Black-Scholes Option Pricing Model (the “Black-Scholes Model”). The
Black-Scholes Model requires judgmental assumptions including
volatility and expected term, both based on historical experience.
The risk-free interest rate is based on U.S. Treasury interest
rates whose term is consistent with the expected term of the
option. The Company determines the assumptions used in the
valuation of option awards as of the date of grant. Differences in
the expected stock price volatility, expected term or risk-free
interest rate may necessitate distinct valuation assumptions at
those grant dates. As such, the Company may use different
assumptions for options granted throughout the year. During the
three months ended March 31, 2022, the valuation assumptions used
to determine the fair value of each option award on the date of
grant were: expected stock price volatility ranged from
158.21% to
158.70%; expected term in years 10 and risk-free interest
rate ranged from
1.52% to
1.98%.
The
grant date fair value of restricted stock and restricted stock
units is based on the closing price of the underlying stock on the
date of the grant.
The
Company has elected to reduce share-based compensation expense for
forfeitures as the forfeitures occur since the Company does not
have historical data or other factors to appropriately estimate the
expected employee terminations and to evaluate whether particular
groups of employees have significantly different forfeiture
expectations.
CEA
Industries Inc.
Notes
to Condensed Consolidated Financial Statements
March
31, 2022
(in US Dollars except share numbers)
(Unaudited)
The
following is a summary of share-based compensation expenses
included in the condensed consolidated statements of operations for
the three months ended March 31, 2022 and 2021:
Schedule of Share-based Compensation
Costs
|
|
2022 |
|
|
2021 |
|
|
|
For the Three Months
Ended
March 31,
|
|
|
|
2022 |
|
|
2021 |
|
Share-based compensation expense
included in: |
|
|
|
|
|
|
|
|
Cost of revenue |
|
$ |
791 |
|
|
$ |
14,135 |
|
Advertising and marketing
expenses |
|
|
2,762 |
|
|
|
6,474 |
|
Product development costs |
|
|
- |
|
|
|
6,694 |
|
Selling,
general and administrative expenses |
|
|
88,964 |
|
|
|
31,833 |
|
Total
share-based compensation expense included in consolidated statement
of operations |
|
$ |
92,517 |
|
|
$ |
59,136 |
|
Included
in the expense for the three months ended March 31, 2021, is an
accrual for $52,794
for the 2021 Annual Employee Incentive Compensation
Plan.
Concentrations
One
customer accounted for 35% of the Company’s
revenue for the three months ended March 31, 2022. Three customers
accounted for 38%, 16%, and 11% of the Company’s
revenue for the three months March 31, 2021.
Three
customers accounted for
44%,
19% and
16% of the Company’s accounts receivable as of March 31,
2022. Two customers accounted for 60%, and 31% of the Company’s
accounts receivable as of March 31, 2021.
Recently Issued
Accounting Pronouncements
In
October 2021, the FASB issued ASU 2021-08, “Business Combinations
(Topic 805): Accounting for Contract Assets and Contract
Liabilities from Contracts with Customers”, which requires
companies to apply ASC 606, “Revenue from Contracts with Customers”
to recognize and measure contract assets and contract liabilities
from contracts with customers acquired in a business combination.
This creates an exception to the general recognition and
measurement principle in ASC 805, which uses fair value. The
guidance is effective for fiscal years beginning after December 15,
2022 and interim periods within those fiscal years. Early adoption
is permitted, and the guidance should be applied prospectively. The
impact of the standard on Company’s consolidated financial
statements is dependent on the size and frequency of any future
acquisitions the Company may complete.
In
May 2021, the FASB issued ASU 2021-04, Issuer’s Accounting for
Certain Modifications or Exchanges of Freestanding
Equity-Classified Written Call Options. This guidance clarifies
and reduces diversity in an issuer’s accounting for modifications
or exchanges of freestanding equity-classified written call options
due to a lack of explicit guidance in the FASB Codification. The
guidance is effective for interim and annual periods beginning
after December 15, 2021. Early adoption is permitted. The guidance
is to be applied prospectively to modifications or exchanges
occurring on or after the effective date. The adoption of this
guidance has not had a material impact on the Company’s
consolidated financial statements.
CEA
Industries Inc.
Notes
to Condensed Consolidated Financial Statements
March
31, 2022
(in US Dollars except share numbers)
(Unaudited)
In
March 2020, the FAS issued ASU No. 2020-04 “Reference Reform
(Topic 848) Facilitation of the Effects of Reference Rate Reform on
Financial Reporting” (“ASU 2020-04”). ASU 2020-04 provides
optional guidance for a limited period of time to ease the
potential burden in accounting for (or recognizing the effects of)
reference rate reform on financial reporting. The amendments are
effective for the Company as of March 12, 2020 through December 31,
2022. The Company does not expect this ASU to have a material
impact on its consolidated results of operations, cash flows and
financial position.
Other
accounting standards that have been issued or proposed by FASB that
do not require adoption until a future date are not expected to
have a material impact on the financial statements upon adoption.
The Company does not discuss recent pronouncements that are not
anticipated to have an impact on or are unrelated to its financial
condition, results of operations, cash flows or
disclosures.
Note
2 – Leases
In
February 2016 the FASB issued ASU 2016-02, Leases (Topic
842) (“ASC 842” or the “new lease standard”). The Company
adopted ASC 842 as of January 1, 2019, using the effective date
method.
The
new standard provides a number of optional practical expedients in
transition. The Company has elected to apply the “package of
practical expedients” which allow the Company to not reassess: (i)
whether existing or expired arrangements contain a lease, (ii) the
lease classification of existing or expired leases, or (iii)
whether previous initial direct costs would qualify for
capitalization under the new lease standard. The Company has also
elected to apply the short-term lease exemption for all leases with
an original term of less than 12 months, for purposes of applying
the recognition and measurements requirements in the new lease
standard.
CEA
Industries Inc.
Notes
to Condensed Consolidated Financial Statements
March
31, 2022
(in US Dollars except share numbers)
(Unaudited)
On
July 28, 2021, the Company entered into an agreement to lease
11,491 square feet of office and
manufacturing space (the “New Facility Lease”), in Louisville, CO.
The New Facility Lease
commenced on November 1, 2021 and continues through January 31,
2027. From November 2021 through January 2022, the monthly
rent was abated. Beginning February 2022, the monthly rent is
$10,055 and will increase by
3% annually every November
through the end of the New Facility Lease term. Pursuant to the New
Facility Lease, the Company made a security deposit of $14,747. The Company has the option
to renew the New Facility Lease for an additional five years.
Additionally, the Company pays the actual amounts for property
taxes, insurance, and common area maintenance. The New Facility
Lease agreement contains customary events of default,
representations, warranties, and covenants.
Upon
commencement of the New Facility Lease, the Company recognized on
the balance sheet an operating lease right-of-use asset and lease
liability in the amount of $582,838. The
lease liability was initially measured as the present value of the
unpaid lease payments at commencement and the ROU asset was
initially measured at cost, which comprises the initial amount of
the lease liability adjusted for lease payments made at or before
the lease commencement date, plus any initial direct costs incurred
less any lease incentives received. The renewal option to extend
the New Facility Lease is not included in the right-of-use asset or
lease liability, as the option is not reasonably certain to be
exercised. The Company regularly evaluates the renewal option and
when it is reasonably certain of exercise, the Company will include
the renewal period in its lease term.
The
lease cost, cash flows and other information related to the
Facility Lease were as follows:
Schedule of Lease Cost
|
|
As of March 31,
2022
|
|
Operating lease
right-of-use asset |
|
$ |
540,444 |
|
Operating lease liability,
current |
|
$ |
112,072 |
|
Operating lease liability,
long-term |
|
$ |
459,482 |
|
|
|
|
|
|
Remaining lease term |
|
|
4.8 years |
|
Discount rate |
|
|
3.63 |
% |
|
|
For
the Three
Months Ended
March 31, 2022
|
|
Operating cash outflow
from operating lease |
|
$ |
20,109 |
|
CEA
Industries Inc.
Notes
to Condensed Consolidated Financial Statements
March
31, 2022
(in US Dollars except share numbers)
(Unaudited)
Future
annual minimum lease payments on the Facility Lease as of March 31,
2022 are as follows:
Schedule of Future Annual Minimum Lease Payments
Years ended December 31, |
|
|
|
2022
(excluding the three months ended March 31, 2022) |
|
$ |
91,095 |
|
2023 |
|
|
124,897 |
|
2024 |
|
|
128,643 |
|
2025 |
|
|
132,503 |
|
2026 |
|
|
136,473 |
|
Thereafter |
|
|
11,654 |
|
Total
minimum lease payments |
|
|
625,265 |
|
Less
imputed interest |
|
|
(53,710 |
) |
Present
value of minimum lease payments |
|
$ |
571,555 |
|
Note
3 – Inventory
Inventory
consisted of the following:
Schedule of Inventory
|
|
March 31, |
|
|
December 31, |
|
|
|
2022 |
|
|
2021 |
|
Finished goods |
|
$ |
913,887 |
|
|
$ |
272,199 |
|
Work in progress |
|
|
971 |
|
|
|
1,050 |
|
Raw materials |
|
|
186,115 |
|
|
|
196,456 |
|
Allowance for
excess & obsolete inventory |
|
|
(95,055 |
) |
|
|
(91,379 |
) |
Inventory,
net |
|
$ |
1,005,918 |
|
|
$ |
378,326 |
|
Overhead
expenses of $16,555 and $13,589 were included in the
inventory balance as of March 31, 2022, and December 31, 2021,
respectively.
The
inventory balance at March 31, 2022 includes $692,195 for inventory in
transit from one of our suppliers that was delivered to our
customer in April of 2022.
Advance
payments on inventory purchases are recorded in prepaid expenses
until title for such inventory passes to the Company. Prepaid
expenses included approximately $1,579,000 and $1,069,000 in advance
payments for inventory for the periods ended March 31, 2022, and
December 31, 2021, respectively.
CEA
Industries Inc.
Notes
to Condensed Consolidated Financial Statements
March
31, 2022
(in US Dollars except share numbers)
(Unaudited)
Note
4 – Property and
Equipment
Property
and equipment consisted of the following:
Schedule of Property and Equipment
|
|
March 31, |
|
|
December 31, |
|
|
|
2022 |
|
|
2021 |
|
Furniture and
equipment |
|
$ |
271,056 |
|
|
$ |
274,472 |
|
Vehicles |
|
|
15,000 |
|
|
|
15,000 |
|
Leasehold
improvements |
|
|
- |
|
|
|
- |
|
Property and equipment, gross |
|
|
286,056 |
|
|
|
289,472 |
|
Accumulated
depreciation |
|
|
(208,817 |
) |
|
|
(212,126 |
) |
Property and
equipment, net |
|
$ |
77,239 |
|
|
$ |
77,346 |
|
Depreciation
expense was $8,556 for the three months
ended March 31, 2022. For the three months ended March 31, 2022,
$1,214 was allocated to cost of sales,
$304 was allocated to inventory
with the remainder recorded as selling, general, and administrative
expense.
Note
5 – Accounts Payable
and Accrued Liabilities
Accounts
payable and accrued liabilities consisted of the
following:
Schedule of Accounts Payable
and Accrued Liabilities
|
|
March 31, |
|
|
December 31, |
|
|
|
2022 |
|
|
2021 |
|
Accounts payable |
|
$ |
729,040 |
|
|
$ |
616,056 |
|
Sales commissions payable |
|
|
9,107 |
|
|
|
27,592 |
|
Accrued payroll liabilities |
|
|
266,456 |
|
|
|
322,873 |
|
Product warranty accrual |
|
|
187,702 |
|
|
|
186,605 |
|
Other accrued
expenses |
|
|
196,723 |
|
|
|
192,463 |
|
Total |
|
$ |
1,389,028 |
|
|
$ |
1,345,589 |
|
Note
6 – Note Payable and
Accrued Interest
On
February 10, 2021, the Company entered into a note payable with its
current bank in the principal amount of $514,200, for working
capital purposes.
The
loan amount bears interest at 1% and is due on February 5, 2026. The loan may be
repaid in advance without penalty. The loan is also potentially
forgivable in full provided proceeds are used for payment of
payroll expenses, rent, utilities and mortgage interest and certain
other terms and conditions are met. If any portion of the loan is
not forgiven, payments will commence 10 months following the end of
the 24-week deferral period. The loan has typical default
provisions, including for change of ownership, general lender
insecurity as to repayment, non-payment of amounts due, defaults on
other debt instruments, insolvency, dissolution or termination of
the business as a going concern and bankruptcy.
On
November 30, 2021, the Company received notice from the bank that
its loan received on February 10, 2021, in the principal amount of
$514,200
and
all accrued interest of $2,832,
was fully forgiven. This gain on loan forgiveness was recorded as
Other Income in the Statement of Operations during the year ended
December 31, 2021.
CEA
Industries Inc.
Notes
to Condensed Consolidated Financial Statements
March
31, 2022
(in US Dollars except share numbers)
(Unaudited)
Note
7 – Commitments and
Contingencies
Litigation
The
Company settled a litigation with a former employee effective March
30, 2021, which included the issuance of 6,667
shares of common stock of the Company, as part of the settlement.
These shares were issued on April 8, 2021, as “restricted
securities,” subject to a lock-up agreement of six months, without
registration rights, and pursuant to a private placement exemption.
The settlement agreement also included mutual releases and no
admission of liability. The cost to the Company of this settlement,
$107,000, in total, has been
recognized in full in Other Expenses during the year ended December
31, 2021. The issuance of the 6,667
shares of common stock (valued at $67,000)
has been recognized in common stock issued during the year ended
December 31, 2021.
From
time to time, in the normal course of its operations, the Company
is subject to litigation matters and claims. Litigation can be
expensive and disruptive to normal business operations. Moreover,
the results of complex legal proceedings are difficult to predict,
and the Company’s view of these matters may change in the future as
the litigation and events related thereto unfold. The Company
expenses legal fees as incurred. The Company records a liability
for contingent losses when it is both probable that a liability has
been incurred and the amount of the loss is known. An unfavorable
outcome to any legal matter, if material, could have an adverse
effect on the Company’s operations or its financial position,
liquidity or results of operations.
Leases
The
Company has a lease agreement for its manufacturing and office
space. Refer to Note 2 Leases above.
Other Commitments
In
the ordinary course of business, the Company enters into
commitments to purchase inventory and may also provide
indemnifications of varying scope and terms to customers, vendors,
lessors, business partners, and other parties with respect to
certain matters, including, but not limited to, losses arising out
of the Company’s breach of such agreements, services to be provided
by the Company, or from intellectual property infringement claims
made by third parties. In addition, the Company has entered into
indemnification agreements with its directors and certain of its
officers and employees that will require the Company to, among
other things, indemnify them against certain liabilities that may
arise by reason of their status or service as directors, officers,
or employees. The Company maintains director and officer insurance,
which may cover certain liabilities arising from its obligation to
indemnify its directors and certain of its officers and employees,
and former officers, directors, and employees of acquired
companies, in certain circumstances.
Note
8 – Temporary
Equity
On
September 28, 2021, the Company sold to an institutional investor
(the “Investor”),
3,300 shares
of Series B Convertible Preferred Stock (“Series B Preferred
Stock”), stated value $1,000
per
share, convertible into shares of common stock, for an
aggregate purchase price of $3,000,000
(“Consideration”). The Company received net proceeds of
approximately $1,260,000
on September 28, 2021, and the balance of approximately $1,365,000
on November 4, 2021.
The
Series B Preferred Stock had an annual dividend of 8% and an initial common
stock conversion price of $8.55. The conversion rate was
subject to adjustment in various circumstances, including stock
splits, stock dividends, pro rata distributions, fundamental
transactions and upon a triggering event and subject to reset if
the common stock of the Company sold in any subsequent equity
transaction, including a qualified offering, was sold at a price
below the then conversion price.
The
Series B Preferred Stock was mandatorily convertible on the third
anniversary of its issuance. All conversions of the Series B
Preferred Stock were subject to a blocker provision of 4.99%.
CEA
Industries Inc.
Notes
to Condensed Consolidated Financial Statements
March
31, 2022
(in US Dollars except share numbers)
(Unaudited)
Probability
of Redemption: As it was considered probable the Series B Preferred
stock would become redeemable outside of the Company’s control, the
Series B Preferred stock was disclosed as temporary equity and was
initially adjusted as of September 30, 2021 to its redemption value
of
120% of
the stated value of $1,000
per
share, or $3,960,000.
As a result, the Company recorded a $2,262,847
non-cash
redemption value adjustment during 2021. This redemption value
adjustment is treated as similar to a dividend on the preferred
stock for GAAP purposes; accordingly, the redemption value
adjustment is therefore added to the “Net Loss” to arrive at “Net
Loss Attributable to Common Shareholders” on the Company’s Consolidated
Statements of Operations. In addition, since the Company did not
have a balance of retained earnings, the redemption value
adjustment was recorded against additional paid-in
capital.
On
February 16, 2022, the Company redeemed
1,650 shares
of its Series B Preferred Stock for payment of $2.016
million
in cash, which included both principal and accrued dividends of
approximately $36,000.
On
February 16, 2022, the remaining
1,650 shares
of the Company’s Series B Preferred Stock were converted into
362,306 shares
of common stock and
703,069 warrants;
170,382 of
the warrants vested immediately, have an indefinite term and an
exercise price of $0.01
(“pre-funded
conversion warrants”), the
balance of
532,688 warrants
also vested immediately, have a term of
5 years
and have an exercise price of $5.00.
The initial common stock conversion price for the shares of Series
B Preferred Stock was $8.55.
However, the terms of the Series B preferred stock were such that
the stock conversion price was to be reduced to
75% of
the offering price in any subsequent qualified public offering of
Company equity instruments, if lower than the common stock
conversion price of $8.55.
The Company’s public offering that closed on February 15, 2022, was
completed at an offering price of $4.13.
Accordingly, the initial common stock conversion price for the
shares of Series B Preferred Stock was reduced from $8.55
to
$3.0975,
representing
75% of
the offering price of $4.13.
As a result, the Company recognized a deemed dividend of $439,999
to
Series B Shareholders in respect of the additional shares of common
stock and warrants they received on the conversion of their shares
of Series B Preferred stock. As the Company does not have a balance
of retained earnings, the deemed dividend was recorded against
additional paid-in capital.
The Company has no remaining Preferred Shares outstanding as of
March 31, 2022.
Note
9 – Stockholders’
Equity (Deficit)
Directors Remuneration
On
January 3, 2022, the Company issued 3,125 non-qualified
stock options under the 2021 Equity Incentive Plan to each of two
existing directors. The options had an exercise price of $4.80, vested immediately and had a
term ending at the earlier of
five years after the date on which the optionee’s continuous
service ends, or the tenth anniversary on which the option was
granted.
On
January 17, 2022, the Company issued an RSU grant of 3,367 shares of
common stock 2021 Equity Incentive Plan to each of two new
directors, 1,684 shares of common stock vested
immediately on grant date and the remaining 1,683 shares of common stock will
vest on January 17, 2023, if the recipient remains in service as an
independent director. 1,684 shares of common stock were
issued to each of the two new directors in settlement of the RSUs
that vested immediately.
Revised Compensation Plan
On
January 17, 2022, the Board of Directors revised the previously
adopted compensation plan. This plan supersedes the plan adopted on
August 20, 2021. The Plan is effective retroactively for the
current independent directors and for independent directors elected
or appointed after the Effective Date. 3,367
restricted stock units in respect of this plan were issued on
January 17, 2022. Cash fees were paid on January 21,
2022.
Reverse Stock Split
On
January 17, 2022, the Company’s Board of Directors approved a
reverse stock split at a ratio of one-for-one hundred and fifty.
The reverse stock split was implemented effective January 27, 2022.
The par value for the Common Stock was not affected.
As a
result of this reverse stock split, the number of the Company’s
shares of common stock issued and outstanding at December 31, 2021
was reduced from 240,125,244
to 1,600,835.
All Common Stock, warrants, options and per share amounts set forth
herein are presented to give retroactive effect to the Reverse
Split for all periods presented.
CEA
Industries Inc.
Notes
to Condensed Consolidated Financial Statements
March
31, 2022
(in US Dollars except share numbers)
(Unaudited)
Change in Authorized Share Capital
In
connection with the aforementioned reverse stock split, the
Company’s Board of Directors approved the reduction of the
authorized capital of the Company to 200,000,000 shares
of common stock and 25,000,000 shares
of preferred stock.
Equity Raise
On
February 10, 2022, the Company signed a firm commitment
underwriting agreement for the public offering of shares of common
stock and warrants, which closed on February 15, 2022. The Company
received net proceeds of approximately $22 million
for the sale of 5,811,138
shares of common stock and 6,572,808 warrants, each
warrant to purchase one share of common stock for five years, exercisable immediately, at
an exercise price of $5.00. The Company also
issued to the representative of the underwriters 290,557
warrants, each warrant to purchase one share of common stock at an
exercise price of $5.1625, during the period commencing
August 9, 2022, and expiring on February 10, 2027.
As of
March 31, 2022, the Company had 200,000,000 shares
authorized at a $.00001 par value. Effective March 31,
2022, 7,784,444
shares of common stock were issued and outstanding. No shares
of preferred stock are issued and outstanding.
Note
10 – Equity Incentive
Plans
2017 Equity Incentive Plan
Under
the Company’s 2017 Equity Incentive Plan, as may be modified and
amended by the Company from time to time (the “2017 Equity Plan”),
the Board of Directors (the “Board”) (or the compensation committee
of the Board, if one is established) may award stock options, stock
appreciation rights (“SARs”), restricted stock awards (“RSAs”),
restricted stock unit awards (“RSUs”), shares granted as a bonus or
in lieu of another award, and other stock-based performance awards.
The 2017 Equity Plan allocates
333,333 shares of the Company’s common stock (“Plan Shares”)
for issuance of equity awards under the 2017 Equity Plan. If any
shares subject to an award are forfeited, expire, or otherwise
terminate without issuance of such shares, the shares will, to the
extent of such forfeiture, expiration, or termination, again be
available for awards under the 2017 Equity Plan.
During
the three months ended March 31, 2022, no shares or options were
issued and
13,333 options were cancelled under the 2017
Plan.
As of
March 31,2022, of the 333,333
shares authorized under the 2017 Plan for equity awards,
163,692 shares have been issued, awards related to
148,905 options remain outstanding, and 20,736
shares remain available for future equity awards.
2021 Equity Incentive Plan
On
March 22, 2021, the Board approved the 2021 Equity Incentive Plan
(the “2021 Equity Plan”), which was approved by the stockholders on
July 22, 2021. The 2021 Equity Plan permits the Board to grant
awards of up to
666,667 shares of common stock. The 2021 Plan provides for
the grant of incentive stock options intended to qualify under
Section 422 of the Internal Revenue Code of 1986, as amended (the
“Code”), non-qualified stock options, stock appreciation rights
(“SARs”), restricted stock awards and restricted stock unit awards
and other equity linked awards to our employees, consultants and
directors. If an equity award (i) expires or otherwise terminates
without having been exercised in full or (ii) is settled in cash
(i.e., the holder of the award receives cash rather than
stock), such expiration, termination or settlement will not reduce
(or otherwise offset) the number of shares of common stock that may
be issued pursuant to this Plan.
CEA
Industries Inc.
Notes
to Condensed Consolidated Financial Statements
March
31, 2022
(in US Dollars except share numbers)
(Unaudited)
During
the three months ended March 31, 2022, the Company issued 3,367 shares of its common stock
to two new independent directors under the 2021 Equity Incentive
Plan, pursuant to the Director Compensation plan adopted in January
2022.
During
the three months ended March 31, 2022, the Company granted awards
for 21,167 non-qualified
stock options to employees under the 2021 Equity Incentive Plan as
described below.
During
the three months ended March 31, 2022, the Company granted awards
for 6,250 non-qualified
stock options to directors under the 2021 Equity Incentive Plan,
pursuant to the Director Compensation plan adopted in August of
2021.
As of
March 31,2022, of the 666,667 shares
authorized under the 2021 Equity Plan, 10,170 relate to restricted
shares issued, 33,408 relate to
outstanding non-qualified stock options, 40,816 relate to
outstanding incentive stock options,
3,367 relate to outstanding restricted stock units and
578,906
shares remain available for future equity awards.
There
was $222,707 in
unrecognized compensation expense for unvested non-qualified stock
options, incentive stock options and restricted stock units at
March 31, 2022 which will be recognized over approximately
3
years.
Non-Qualified and Incentive Stock Options
A
summary of the non-qualified stock options and incentive stock
options granted to employees and consultants under the 2017 and
2021 Equity Plans during the three months ended March 31, 2022, are
presented in the table below:
Schedule of Stock Option
Activity
|
|
Number of
Options
|
|
|
Weighted
Average
Exercise
Price
|
|
|
Weighted
Average
Remaining
Contractual
Term
|
|
|
Aggregate
Intrinsic
Value
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding, December 31, 2021 |
|
|
158,174 |
|
|
$ |
10.99 |
|
|
|
7.6 |
|
|
$ |
- |
|
Granted |
|
|
21,167 |
|
|
$ |
3.55 |
|
|
|
9.8 |
|
|
$ |
4,650
|
|
Exercised |
|
|
- |
|
|
$ |
- |
|
|
|
- |
|
|
$ |
- |
|
Forfeited |
|
|
(13,333 |
) |
|
$ |
9.15 |
|
|
|
0.0 |
|
|
$ |
- |
|
Expired |
|
|
- |
|
|
$ |
- |
|
|
|
- |
|
|
$ |
- |
|
Outstanding, March 31, 2022 |
|
|
166,007 |
|
|
$ |
10.18 |
|
|
|
8.2 |
|
|
$ |
4,650 |
|
Exercisable, March 31, 2022 |
|
|
118,828 |
|
|
$ |
11.89 |
|
|
|
7.6 |
|
|
$ |
610 |
|
CEA
Industries Inc.
Notes
to Condensed Consolidated Financial Statements
March
31, 2022
(in US Dollars except share numbers)
(Unaudited)
During
the three months ended March 31, 2022, we issued a total of
21,167 stock options to employees as
follows:
|
● |
6,167 stock options were issued to
three new employees. The vesting of these options ranges from
immediate to three years, have a term of
10 years and an exercise price
ranging from $4.80 to $6.90. |
|
● |
15,000 stock options were issued to
our newly appointed Chief Financial Officer. The options vest as follows: 2,000
vested immediately, 3,000 on March 11, 2023, 5,000 on March 11,
2024, and 5,000 on March 11, 2025. The options have a term
of 10 years and an exercise price
of $2.20. |
|
● |
During
the three months ended March 31, 2022, 1,667 fully vested
stock options and 11,667 unvested stock
options were forfeited following the departure of one former
employee. |
A
summary of non-vested non-qualified stock options activity for
employees and consultants under the 2017 and 2021 Equity Plans for
the three months ended March 31, 2022, are presented in the table
below:
Summary of Non-vested Non-qualified Stock
Option Activity
|
|
Number of
Options
|
|
|
Weighted
Average
Grant-Date
Fair Value
|
|
|
Aggregate
Intrinsic
Value
|
|
|
Grant-Date
Fair Value
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nonvested, December 31, 2021 |
|
|
41,846 |
|
|
$ |
7.65 |
|
|
$ |
- |
|
|
$ |
320,122 |
|
Granted |
|
|
21,167 |
|
|
$ |
3.51 |
|
|
$ |
- |
|
|
$ |
74,296 |
|
Vested |
|
|
(4,167 |
) |
|
$ |
4.50 |
|
|
$ |
- |
|
|
$ |
(18,751 |
) |
Forfeited |
|
|
(11,667 |
) |
|
$ |
9.01 |
|
|
$ |
- |
|
|
$ |
(105,120 |
) |
Expired |
|
|
- |
|
|
$ |
- |
|
|
$ |
- |
|
|
$ |
- |
|
Nonvested, March 31, 2022 |
|
|
47,179 |
|
|
$ |
5.73 |
|
|
$ |
- |
|
|
$ |
270,547 |
|
For
the three months ended March 31, 2022 and March 31, 2021, the
Company recorded $32,939 and $0 as compensation expense
related to vested options issued to employees and consultants, net
of forfeitures, respectively.
A
summary of the non-qualified stock options granted to directors
under the 2017 Equity Plan and the 2021 Equity Plan, during the
three months ended March 31, 2022, are presented in the table
below:
Schedule of Stock Option
Activity
|
|
Number of
Options
|
|
|
Weighted
Average
Exercise
Price
|
|
|
Weighted
Average
Remaining
Contractual
Term
|
|
|
Aggregate
Intrinsic
Value ($000)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding, December 31, 2021 |
|
|
50,872 |
|
|
$ |
10.02 |
|
|
|
6.6 |
|
|
$ |
- |
|
Granted |
|
|
6,250 |
|
|
$ |
4.80 |
|
|
|
9.8 |
|
|
$ |
- |
|
Exercised |
|
|
- |
|
|
$ |
- |
|
|
|
- |
|
|
$ |
- |
|
Forfeited/Cancelled |
|
|
- |
|
|
$ |
- |
|
|
|
- |
|
|
$ |
- |
|
Expired |
|
|
- |
|
|
$ |
- |
|
|
|
- |
|
|
$ |
- |
|
Outstanding, March 31, 2022 |
|
|
57,122 |
|
|
$ |
9.44 |
|
|
|
6.7 |
|
|
$ |
- |
|
Exerciseable, March 31, 2022 |
|
|
57,122 |
|
|
$ |
9.44 |
|
|
|
6.7 |
|
|
$ |
- |
|
A
summary of non-vested non-qualified stock options activity for
directors under the 2017 Equity Plan and the 2021 Equity Plan, for
the three months ended March 31, 2022, are presented in the table
below:
CEA
Industries Inc.
Notes
to Condensed Consolidated Financial Statements
March
31, 2022
(in US Dollars except share numbers)
(Unaudited)
Summary of Non-vested Non-qualified Stock
Option Activity
|
|
Number of
Options
|
|
|
Weighted
Average
Grant-Date
Fair Value
|
|
|
Aggregate
Intrinsic
Value
|
|
|
Grant-Date
Fair Value
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nonvested, December 31, 2021 |
|
|
- |
|
|
$ |
- |
|
|
$ |
- |
|
|
$ |
- |
|
Granted |
|
|
6,250 |
|
|
$ |
4.80 |
|
|
$ |
(14,313 |
) |
|
$ |
29,688 |
|
Vested |
|
|
(6,250 |
) |
|
$ |
4.80 |
|
|
$ |
14,313 |
|
|
$ |
(29,688 |
) |
Forfeited |
|
|
- |
|
|
$ |
- |
|
|
$ |
-
|
|
|
$ |
- |
|
Expired |
|
|
- |
|
|
$ |
- |
|
|
$ |
- |
|
|
$ |
- |
|
Nonvested, March 31, 2022 |
|
|
- |
|
|
|
|
|
|
$ |
- |
|
|
$ |
- |
|
During
the three months ended March 31, 2022 and March 31, 2021, the
Company incurred $29,656 and $6,342 respectively, as
compensation expense related to 6,250 and
3,333 vested
options, respectively, issued to directors.
Effective
January 3, 2022, the Company issued 6,250
non-qualified stock options under the 2021 Equity Plan to its then
current directors. The options vested upon grant. The options have
a term of 10 years and an exercise price
equal to the closing price of the Company’s common stock on The OTC
Markets on the day immediately preceding the grant date.
Restricted Stock Units
Effective
January 17,2022, the Company issued 6,734 restricted stock units
(RSUs) under the 2021 Equity Plan to newly appointed directors.
3,367 of these RSUs vested upon
grant and the remining 3,367 will vest on January 17,
2023.
The
Company recorded $29,923 during the three
months ended March 31, 2022, as compensation expense related to
vested RSUs issued to directors.
Schedule of Restricted Stock Units
Activity
|
|
Number of
Units
|
|
|
Weighted
Average
Grant-Date
Fair Value
|
|
|
Aggregate
Intrinsic Value
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding, December 31, 2021 |
|
|
- |
|
|
$ |
- |
|
|
$ |
- |
|
Granted |
|
|
6,734 |
|
|
$ |
7.42 |
|
|
$ |
- |
|
Vested and settled
with share issuance |
|
|
(3,367 |
) |
|
$ |
7.42 |
|
|
$ |
- |
|
Forfeited/canceled |
|
|
- |
|
|
$ |
- |
|
|
$ |
- |
|
Outstanding, March 31, 2022 |
|
|
3,367 |
|
|
$ |
7.42 |
|
|
$ |
- |
|
CEA
Industries Inc.
Notes
to Condensed Consolidated Financial Statements
March
31, 2022
(in US Dollars except share numbers)
(Unaudited)
Note
11 - Warrants
The
following table summarizes information with respect to outstanding
warrants to purchase common stock during the three months ended
March 31, 2022:
Schedule of Outstanding Warrants to Purchase
Common Stock
|
|
|
|
|
Weighted
Average
|
|
|
Weighted
Average
Remaining
|
|
|
Aggregate |
|
|
|
Number |
|
|
Exercise |
|
|
Life |
|
|
Intrinsic |
|
|
|
Outstanding |
|
|
Price |
|
|
In Months |
|
|
Value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at December 31, 2021 |
|
|
227,719 |
|
|
$ |
9.59 |
|
|
|
33 |
|
|
$ |
0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issued |
|
|
7,566,435 |
|
|
$ |
4.89 |
|
|
|
58 |
* |
|
$ |
425,955 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercised |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expired |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at March 31,
2022 |
|
|
7,794,154 |
|
|
$ |
5.03 |
|
|
|
58 |
* |
|
$ |
425,955 |
|
* |
Excludes
170,382 warrants with an indefinite life. |
The
following table summarizes information about warrants outstanding
at March 31, 2022:
Schedule of Warrants
Outstanding
|
|
|
Warrants |
|
|
Weighted Average |
|
Exercise
price |
|
|
Outstanding |
|
|
Months
Outstanding |
|
|
|
|
|
|
|
|
|
|
9.45 |
|
|
|
192,982 |
|
|
|
30 |
|
|
|
|
|
|
|
|
|
|
|
|
|
10.40 |
|
|
|
34,737 |
|
|
|
31 |
|
|
|
|
|
|
|
|
|
|
|
|
|
5.00 |
|
|
|
7,105,496 |
|
|
|
59 |
|
|
|
|
|
|
|
|
|
|
|
|
|
5.16 |
|
|
|
290,557 |
|
|
|
59 |
|
|
|
|
|
|
|
|
|
|
|
|
|
0.01 |
|
|
|
170,382 |
|
|
|
Indefinite
Life |
|
|
|
|
|
|
7,794,154 |
|
|
|
58 |
* |
* |
Excludes
170,382 warrants with an indefinite life. |
CEA
Industries Inc.
Notes
to Condensed Consolidated Financial Statements
March
31, 2022
(in US Dollars except share numbers)
(Unaudited)
Q3 2021 Warrants Issued to Series B Preferred
Stockholder
On
September 28, 2021, the Company entered into a Securities Purchase
Agreement with an institutional investor, pursuant to which the
investor purchased from the Company 3,300 shares of convertible
Series B Preferred Stock with a stated value of $1,000 per share, or $3,300,000 of stated value in the
aggregate, and a warrant to purchase up to 192,982 shares of common stock of
the Company for an aggregate purchase price of $3,000,000. The warrant is exercisable
until September 28, 2024, at an exercise price of $9.45, subject to
adjustment for stock splits, stock dividends and other typical
adjustments and changes in capitalization, including mergers and
acquisitions and distribution of rights.
Q3 2021 Warrants Issued to Series B Preferred Placement
Agent
In
connection with the sale of the shares of convertible Series B
Preferred Stock described above, the Company issued 34,737 warrants to the
placement agent and its designees. Half of the warrants were issued
on September 28, 2021, and the second half were issued on November
3, 2021, and are exercisable commencing February 28, 2022 and May
3, 2022, respectively, until September 28, 2024 and November 3,
2024, respectively. The exercise price per share of the warrants is
$10.40, subject to
adjustment for stock splits, stock dividends and other typical
adjustments and changes in capitalization, including mergers and
acquisitions and distribution of rights.
Q1 2022 Investor Warrants
On
February 15, 2022, the Company issued 5,811,138 investment
units for aggregate gross proceeds of $24,000,000, or
$4.13 per unit. Each unit
consisted of one share of the Company’s common stock and one
warrant for the purchase of one share of the Company’s common
stock. The warrants vested immediately, had a term of 5 years and an exercise price of
$5.00.
Q1 2022 Overallotment Warrants
Further
on February 15, 2022, in connection the Company’s issuance of
5,811,138 investment
units for aggregate gross proceeds of $24,000,000, or
$4.13 per unit as described
above, a further 761,670 warrants were issued in
connection with the subscription for substantially all of the
available 15% overallotment warrants. The
warrants were acquired for consideration of $0.01 per warrant, vested
immediately, had a term of 5 years and an exercise price of
$5.00.
Q1 2022 Underwriter Warrants
Further
on February 15, 2022, in connection the Company’s issuance of
5,811,138 investment units for
aggregate gross proceeds of $24,000,000, or
$4.13 per unit described above,
the Company also issued representatives of the underwriters
290,557 warrants. Each warrant entitled the holder to
purchase one share of common stock at an exercise price of
$5.1625, during the period commencing
August 9, 2022, and expiring on February 10, 2027.
Q1 2022 Series B Preferred Shares Pre-Funded Conversion
Warrants
On
February 16, 2022, in connection with the conversion of 1,650 shares of Series B
Preferred Stock into 362,306 shares of the Company’s
common stock, the Series B Preferred Shareholder was issued with
170,382 pre-funded conversion
warrants. Each warrant entitled the holder to purchase one share of
common stock at an exercise price of $0.01, vested immediately and had an
indefinite life.
CEA
Industries Inc.
Notes
to Condensed Consolidated Financial Statements
March
31, 2022
(in US Dollars except share numbers)
(Unaudited)
Q1 2022 Series B Preferred Shares Conversion
Warrants
Further
on February 16, 2022, in connection with the conversion of
1,650 shares of Series B
Preferred Stock into 362,306 shares of the Company’s
common stock, the Series B Preferred Shareholder was also issued
with
532,688 Series B Preferred shares conversion warrants. Each
warrant entitled the holder to purchase one share of common stock
at an exercise price of $5.00, vested immediately and had a
term of 5 years.
Note
12 – Income
Taxes
As of
March 31, 2022, the Company has U.S. federal and state net
operating losses (“NOLs”) of approximately $22,514,000,
of
which $11,196,000
will
expire, if not utilized, in the years 2034 through 2037, however,
NOLs generated subsequent to December 31, 2017 do not expire but
may only be used against taxable income to
80%. In
response to the novel coronavirus COVID-19, the Coronavirus Aid,
Relief, and Economic Security Act temporarily repealed the
80%
limitation for NOLs arising in 2018, 2019 and 2020.
In
addition, pursuant to Section 382 of the Internal Revenue Code of
1986, as amended, use of the Company’s NOLs carryforwards may be
limited in the event of cumulative changes in ownership of more
than
50%
within a three-year period. In addition, under Section 382 of the
Internal Revenue Code of 1986, as amended (the “Code”), and
corresponding provisions of state law, if a corporation undergoes
an “ownership change,” which is generally defined as a greater than
50%
change, by value, in its equity ownership over a
three-year period, the
corporation’s ability to use its pre-change net operating loss
carryforwards and other pre-change tax attributes to offset its
post-change income or taxes may be limited. Our sale of securities,
both in September 2021 and February 2022, will need to be
considered for determination of any “ownership change” that we have
undergone during a determination period. If an ownership change
occurs and our ability to use our net operating loss carryforwards
is materially limited, it would harm our future bottom-line
operating results by effectively increasing our future tax
obligations
The
Company must assess the likelihood that its net deferred tax assets
will be recovered from future taxable income, and to the extent the
Company believes that recovery is not likely, the Company
establishes a valuation allowance. Management’s judgment is
required in determining the Company’s provision for income taxes,
deferred tax assets and liabilities, and any valuation allowance
recorded against the net deferred tax assets. The Company recorded
a full valuation allowance as of March 31, 2022 and December 31,
2021. Based on the available evidence, the Company believes it is
more likely than not that it will not be able to utilize its net
deferred tax assets in the foreseeable future. The Company intends
to maintain valuation allowances until sufficient evidence exists
to support the reversal of such valuation allowances. The Company
makes estimates and judgments about its future taxable income that
are based on assumptions that are consistent with the Company’s
plans. Should the actual amounts differ from the Company’s
estimates, the carrying value of the Company’s deferred tax assets
could be materially impacted.
Note
13 – Related Party
Transactions
The
Company entered into a manufacturer representative agreement with
RSX Enterprises (“RSX”) in March 2021 to become a non-exclusive
representative for the Company to assist in marketing and
soliciting orders. James R. Shipley, a current director of the
Company, has a significant ownership interest in RSX.
Under
the manufacturer representative agreement, RSX will act as a
non-exclusive representative for the Company within the United
States, Canada and Mexico and may receive a commission for
qualified customer leads. The agreement had an initial term through
December 31, 2021 with automatic one-year renewal terms unless
prior notice is given 90 days prior to each annual expiration.
During the three months ended March 31, 2022, the Company paid
$7,555 in commissions under
this agreement.
Note
14 – Subsequent
Events
In
accordance with ASC 855, Subsequent Events, the Company has
evaluated all subsequent events through the date the financial
statements were available to be issued. No material subsequent
events occurred after March 31, 2022, other than as set out
below:
On
April 1, 2022, 31,793 non-qualified
stock options were issued to 21 employees in respect of the
Company’s 2021 Annual Incentive Awards. The options vested
immediately, have a term of 10 years and an
exercise price of $2.51. The expense in
respect of this issuance had been fully in fully accrued in
2021.
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL
CONDITION AND RESULTS OF OPERATIONS
The
following discussion should be read in conjunction with our
unaudited condensed consolidated financial statements and related
notes included elsewhere in this Quarterly Report, which include
additional information about our accounting policies, practices,
and the transactions underlying our financial results, as well as
with our audited consolidated financial statements included in our
Annual Report on Form 10-K for the year ended December 31, 2021, as
filed with the SEC. In addition to historical information, the
following discussion and other parts of this Quarterly Report
contain forward-looking information that involves risks and
uncertainties. Our actual results could differ materially from
those anticipated by such forward-looking information due to the
factors discussed under “Cautionary Statements” appearing elsewhere
herein and the risks and uncertainties described or identified in
“Item 1A – Risk Factors” in our Annual Report on Form 10-K for the
year ended December 31, 2021, as updated from time to time in the
Company’s filings with the SEC, and Part II, Item 1A of this
Quarterly Report entitled “Risk Factors.”
Non-GAAP Financial Measures
To
supplement our financial results on U.S. generally accepted
accounting principles (“GAAP”) basis, we use non-GAAP measures
including net bookings, backlog, as well as adjusted net income
(loss) which reflects adjustments for certain non-cash expenses
such as stock-based compensation, certain debt-related items and
depreciation expense. We believe these non-GAAP measures are
helpful in understanding our past performance and are intended to
aid in evaluating our potential future results. The presentation of
these non-GAAP measures should be considered in addition to our
GAAP results and are not intended to be considered in isolation or
as a substitute for financial information prepared or presented in
accordance with GAAP. We believe these non-GAAP financial measures
reflect an additional way to view aspects of our operations that,
when viewed with our GAAP results, provide a more complete
understanding of factors and trends affecting our business. For
purposes of this Quarterly Report, (i) “adjusted net income (loss)”
and “adjusted operating income (loss)” mean GAAP net income (loss)
and operating income (loss), respectively, after adjustment for
non-cash equity compensation expense, debt-related items and
depreciation expense, and (ii) “net bookings” means new sales
contracts executed during the quarter for which we received an
initial deposit, net of any adjustments including cancellations and
change orders during the quarter.
Our
backlog, remaining performance obligations and net bookings may not
be indicative of future operating results, and our customers may
attempt to renegotiate or terminate their contracts for a number of
reasons, including delays in or inability to obtain project
financing or licensing or abandonment of the project entirely.
Accordingly, there can be no assurance that contracts included in
the backlog or remaining performance obligations will actually
generate revenues or when the actual revenues will be
generated.
Overview
CEA
Industries is an engineering and design company focused on selling
environmental control and other technologies and services to the
Controlled Environment Agriculture (“CEA”) industry. The CEA
industry uses technology-based methods to grow crops in a way that
provides protection from the outdoor elements; these methods have
traditionally included indoor agriculture and vertical farming. The
CEA industry aims to optimize the use of horticultural resources
such as water, energy, space, capital and labor, to create an
agriculture business that is more efficient and more productive
than traditional farming methods.
Headquartered
in Colorado, we leverage our experience in the CEA industry to
bring our customers a variety of value-added technology solutions
that help improve their overall crop quality and yield, optimize
energy and water efficiency, and satisfy the evolving state and
local codes, permitting and regulatory requirements. We do this by
offering our customers a variety of principal service and product
offerings that include: (i) architectural design and licensed
engineering of commercial scale thermodynamic systems specific to
cultivation facilities, (ii) liquid-based process cooling systems
and other climate control systems, (iii) air handling equipment and
systems, (iv) LED lighting, benching and racking solutions for
indoor cultivation, (v) automation and control devices, systems and
technologies used for environmental, lighting and climate control,
and (vi) preventive maintenance services for CEA
facilities.
Currently,
our revenue stream is derived primarily from supplying our
products, services and technologies to commercial indoor facilities
operating in the cannabis industry. Our customers include state and
provincial-regulated CEA growers located in the U.S., Canada and
other international locations. They are focused on building new CEA
facilities and expanding or retrofitting existing CEA facilities.
Our customers operate CEA facilities that range in size from
several thousand square feet to more than 100,000 square
feet.
CEA
growers currently face a challenging business environment that
includes high energy costs, water usage and conservation issues,
and continuously evolving waste removal regulations. In addition to
these issues, our cannabis growing customers face increasingly
rigorous quality standards and declining cannabis prices in a
growing industry whose standards are constantly evolving. A primary
challenge for our customers involves finding innovative ways to
reduce energy costs. On average, 50% of our customers’ energy costs
are driven by HVACD systems and another 40% by lighting
systems.
We
support our clients by providing integrated mechanical, electrical,
and plumbing (“MEP”) engineering design, proprietary and curated
environmental control equipment, and automation offerings that
serve the CEA industry. In addition, we believe we are among the
leading experts in engineering environmental control systems for
CEA facilities, which is commonly viewed as the most challenging
component of a CEA facility’s technical infrastructure. Over our 16
years in business, we have served over 200 commercial indoor CEA
facilities. While a professional engineer (“PE”) license is not
required in any other design component of a CEA facility, such a
license is required for the design of a CEA facility’s
environmental control equipment, and our senior engineers hold PE
licenses.
We
believe our customers partner with us because we have the
reputation and experience to help them make cost-conscious and
effective decisions on their environmental and climate control
systems. Our clients are focused on their crops and rely on us to
partner with them on ways to optimize their CEA facility. We are
also mindful of the evolving and substantial environmental
sustainability standards and concerns raised by governments,
consumers and other stakeholders. CEA facilities are resource
intensive, and a growing list of states have implemented building
code changes that limit energy consumption in cultivation
facilities. Energy and resource efficiency is a high priority to us
as engineers, and the senior engineers on our team hold the
Leadership in Energy and Environmental Design (“LEED”) credential.
In addition, our CEO helped build a cleantech company, and is a
published author in the energy efficient technologies space. We
believe this sustainability-focused technical experience is a
unique advantage that our customers value when working with
us.
While
the Company historically focused on HVACD systems, in May of 2021,
we announced an initiative to expand our product and service
offerings to include most of the technical product and service
infrastructure requirements associated with building and
retrofitting CEA facilities, as well as post-build recurring
maintenance services. Our engineering design services and
consulting expertise facilitates early engagement with our
customers at the pre-build and construction phases, and this
enables us to better understand our customers’ goals at the
beginning of a project, and provide the associated infrastructure
products and services to reach those goals. Through our prior
engagements with customers, we have built long-term relationships
with our existing customers, which we plan to leverage and build on
in the future.
We
have three core assets that we believe will support us as we pursue
our business strategy. First, we enjoy strong relationships with
relevant stakeholders in the CEA industry. Largely focused in the
cannabis segment, our partnerships include relationships with new
and existing growers, capital providers, consultants, independent
contractors, and numerous others. Second, our experience in this
industry over time has built up specialized engineering know-how
and experience. We have been serving indoor cultivators since 2006
and designing CEA cultivation facilities since 2016. Since then, we
have tested and solidified best practices from designing
environmental control systems for CEA cultivation facilities.
Finally, we have a line of proprietary environmental control
products that support the specific growing environments that our
customers want. We believe these products offer significant
benefits to our customers and we are in the process of expanding
our product slate.
Shares
of our common stock and warrants are traded on the Nasdaq Capital
Markets under the ticker symbol “CEAD” and “CEADW”,
respectively.
Impact
of the COVID-19 Pandemic on Our Business
The
COVID-19 pandemic has prompted national, regional, and local
governments, including those in the markets that the Company
operates in, to implement preventative or protective measures to
control its spread. As a result, there have been disruptions in
business operations around the world, with an impact on our
business.
In
response to the COVID-19 pandemic and the associated government and
business response, the Company took and continues to take measures
to adjust its operations as necessary. In early 2020 the Company
responded to reduced orders by reducing expenses in an effort to
preserve cash. As 2020 progressed and our sales rebounded, and we
were able to obtain additional funds through a forgivable bank
loan, we restored our workforce increased our operations. Many of
the expense reductions were reversed by the end of 2021 when orders
picked up and the overall business climate improved. Because the
pandemic continues in different parts of the world and in different
ways in the United States, the Company continues to actively
monitor its operations.
We
are experiencing unexpected and uncontrollable delays with our
international supply of products and shipments from vendors due to
a significant increase in shipments to U.S. ports, compounded by a
reduction in cargo being shipped by air, a general shortage of
containers, and a shortage of domestic truck driver availability.
While these delays have moderately improved in recent months, we,
along with many other importers of goods across all industries,
continue to experience severe congestion and extensive wait times
for carriers at ports across the United States. In addition,
restrictions imposed by local, state and federal agencies due to
the COVID-19 pandemic have led to reduced personnel of importers,
government staff and others in our supply chain. We have been
working diligently with our network of freight partners and
suppliers to expedite delivery dates and provide solutions to
reduce further impact and delays. However, we are unable to
determine the full impact of these delays and how long they will
continue as they are out of our control.
While
the Company is continuing to navigate the financial, operational,
and personnel challenges presented by the COVID-19 pandemic, the
full extent of the impact of COVID-19 on our operational and
financial performance will depend on future developments, including
the duration and spread of the pandemic, the potential uncertainty
related to (and proliferation of) new strains, and related actions
taken by federal, state, local and international government
officials, to prevent and manage the spread of COVID-19. All of
these efforts are uncertain, out of our control, and cannot be
predicted at this time.
Impact of Ukranian Conflict
Currently, we believe that the conflict between Ukraine and Russia
does not have any direct impact on our operations, financial
condition or financial reporting. We believe the conflict will have
only a general impact on our operations in the same manner as it is
having a general impact on all businesses that have their
operations limited to North America resulting from international
sanction and embargo regulations, possible shortages of goods and
goods incorporating parts that may be supplied from the Ukraine or
Russia, supply chain challenges, and the international and US
domestic inflationary results of the conflict and government
spending for and funding of our country’s response. As our
operations are related only to the North American controlled
agricultural industry, largely within the cannabis space, we do not
believe we will be targeted for cyber-attacks. We have no
operations in the countries directly involved in the conflict or
are specifically impacted by any of the sanctions and embargoes, as
we principally operate in the United States and Canada. We do not
believe that the conflict will have any impact on our internal
control over financial reporting. Other than general securities
market trends, we do not have reason to believe that investors will
evaluate the company as having special risks or exposures related
to the Ukranian conflict.
Our
Corporate Strategy
Our
strategy for growing the Company and increasing shareholder value
is informed by two key pillars:
● |
Pursue
Organic Growth Opportunities |
● |
Execute
on Consolidation Opportunities |
Pursue
aggressive organic growth. According to New Frontier Data and
Grandview Research, the legal cannabis market and the global indoor
farming markets are forecasted to grow at a 15% annual rate for the
foreseeable future. This is largely driven by the cannabis
cultivation market we currently focus on, and the rapidly growing
popularity of the vertical farming market.
We
are well positioned to build our business by serving both of these
segments, by servicing current and future customers to the CEA
industry, and by expanding our customer base to include indoor
farming growers. In May of 2021 we announced a series of pivots, to
better enable the Company to grow organically:
Expansion to New Markets. We expanded our business
development plan to include the pursuit of non-cannabis CEA
facilities, which includes indoor cultivation farms and other CEA
technology users outside of the cannabis industry. This expansion
has approximately doubled our potential addressable market without
any additional upfront retrofit costs to our Company.
Expansion of Product Offering. As previously noted, the
Company historically focused on offering HVACD systems to help our
existing CEA clients manage their environmental control issues.
While significant, this offering represented approximately one
third of the total slate of potential products and services
required to help a grower build and maintain a CEA facility. We
continue to believe that our clients want to focus on growing
plants, while leaving the technical infrastructure buildout and
maintenance to a more experienced partner. As part of our May 2021
initiative, we expanded our product and service offerings by
including almost all of the primary technologies and services
required to build and maintain a CEA facility. This expansion
includes architectural design, lighting, benching, sensing &
control systems, and CO2 dosing and control. It also
includes maintenance services and other post-build products and
services that create more recurring revenue streams than the
product set we traditionally offered.
For
example, by offering Facility Selection & Design services, we
plan to establish ‘pre-build’ customer relationships with prospects
at the earliest opportunity in the lifecycle of the CEA facility.
From there, we plan to offer nearly every piece of the technical
infrastructure required in a facility, engaging with our customers
at the earliest possible moment to provide all products and
services required for the buildout of their CEA facility. Once a
CEA facility is built, our Preventive Maintenance Services will
provide recurring revenue, as we maintain the productivity of the
facility for the facility’s full life.
We
believe that we are uniquely positioned to engineer all of the
complex components of a CEA facility into a more integrated and
coordinated system, because of our dedicated engineering staff and
our experience in over 800 projects including over 200 commercial
facilities. We have built a wide network of technology vendors from
which we curate a selection of the best products. We are the
leading experts in applying the most challenging component of the
technical infrastructure, the environmental controls. As a result,
we have the knowledge required to engineer the interactions among
the required components. The reputation we have built and the
relationships we have established as experts in the complex
environmental control space positions us to engineer the
interactions among the other key components. We believe this effort
will grow revenues from our existing platform in the
future.
Corporate Name Rebrand. In November of 2021 we changed the
name of our parent company from Surna Inc. to CEA Industries Inc.
We believe this name better demonstrates the breadth of both our
newly expanded product offering and our ability to serve the
broader CEA industry in segments beyond traditional cannabis
cultivation. We believe this name will more clearly identify our
business to prospects and make us easier to find on various social
media and search engine platforms. In January 2022, we moved our
environmental controls operations to Surna Cultivation Technologies
LLC, a newly formed subsidiary of CEA Industries Inc., in order to
separate our environmental controls business from other businesses
we plan to pursue as we expand our product and service
offerings.
Seek
strategic relationships, mergers, and acquisitions to add to our
existing business. We have been involved in over 800
cultivation projects over 16 years. This experience has exposed us
to almost all of the ancillary and primary product and service
components within a CEA facility, including lighting, irrigation,
HVACD, fertigation, sensors, controls, CO2 dosing,
monitoring, facility power availability, and energy consumption.
Exposure to these primary components has built a uniquely
well-informed view of the value contribution from various primary
services and components on offer in the marketplace.
We
believe that this knowledge will help us identify opportunities to
acquire products and services for strategic relationships and
potential acquisitions. As we evaluate the state of the CEA
industry and the various industry participants, we see significant
opportunity for the industry to create value through consolidation.
As a growing industry, CEA has a significant need for capital and a
recognition that not all companies can be funded for growth. We
believe this positions us well as we identify partners whose
business platforms are complementary to our business
platform.
Finally,
members of our team have extensive experience in identifying,
evaluating and acquisitions that are accretive and create long-term
value for our shareholders. We believe that assets on our platform
can benefit our shareholders via synergies and scale economics. For
certain component providers, we believe that our public stock and
strong existing platform of products, expertise, and marketing
reach will make us an attractive partner for a potentially
accretive, value creating partnership.
Our
Bookings, Backlog and Revenue
During
the three months ended March 31, 2022, we executed new sales
contracts with a total contract value of $2,347,000. During this
same period, we had positive change orders of $159,000 and
cancellations of $401,000. The cancellations were based on
discussions with customers who have abandoned their projects. After
adjustments for these change orders and cancellations, our net
bookings in the three months ended March 31, 2022 were $2,105,000,
representing a decrease of $1,888,000 (or 47%) from net bookings of
$3,993,000 in the fourth quarter of 2021.
Our
backlog at March 31, 2022 was $11,179,000, an increase of $361,000,
or 3%, from December 31, 2021. The increase in backlog is the
result of lower revenue in the first quarter. Our backlog at March
31, 2022 includes booked sales orders of $2,217,000 (20% of the
total backlog) from several customers that we do not expect to be
realized until 2023. We believe the sales orders in this portion of
our backlog have an elevated level of risk and may, ultimately, be
delayed or cancelled by our customers. Therefore, investors should
not view backlog as earned revenue.
The
following table sets forth: (i) our beginning backlog (the
remaining contract value of outstanding sales contracts for which
we have received an initial deposit as of the previous period),
(ii) our net bookings for the period (new sales contracts executed
during the period for which we received an initial deposit, net of
any adjustments including cancelations and change orders during the
period), (iii) our recognized revenue for the period, and (iv) our
ending backlog for the period (the sum of the beginning backlog and
net bookings, less recognized revenue).
|
|
For the quarter ended |
|
|
|
March 31,
2021
|
|
|
June 30,
2021
|
|
|
September 30,
2021
|
|
|
December 31,
2021
|
|
|
March 31,
2022
|
|
Backlog, beginning balance |
|
$ |
8,448,000 |
|
|
$ |
11,578,000 |
|
|
$ |
7,987,000 |
|
|
$ |
9,881,000 |
|
|
$ |
10,818,000 |
|
Net bookings,
current period |
|
$ |
5,497,000 |
|
|
$ |
919,000 |
|
|
$ |
5,600,000 |
|
|
$ |
3,993,000 |
|
|
$ |
2,105,000 |
|
Recognized revenue, current period |
|
$ |
2,367,000 |
|
|
$ |
4,510,000 |
|
|
$ |
3,706,000 |
|
|
$ |
3,056,000 |
|
|
$ |
1,744,000 |
|
Backlog,
ending balance |
|
$ |
11,578,000 |
|
|
$ |
7,987,000 |
|
|
$ |
9,881,000 |
|
|
$ |
10,818,000 |
|
|
$ |
11,179,000 |
|
The
completion of a customer’s new build facility project is
dependent upon the customer’s ability to secure funding and real
estate, obtain a license and then build their cultivation facility
so they can take possession of the equipment. Accordingly, the time
it takes for these customers to complete a new build project, which
corresponds to when we are able to recognize revenue, is driven by
numerous factors including: (i) the large number of first-time
participants interested in the indoor cannabis cultivation
business; (ii) the complexities and uncertainties involved in
obtaining state and local licensure and permitting; (iii) local and
state government delays in approving licenses and permits due to
lack of staff or the large number of pending applications,
especially in states where there is no cap on the number of
cultivators; (iv) the customer’s need to obtain cultivation
facility financing; (v) the time needed, and coordination required,
for our customers to acquire real estate and properly design and
build the facility (to the stage when climate control systems can
be installed); (vi) the large price tag and technical complexities
of the climate control and air sanitation system; (vii) the
availability of power; and (viii) delays that are typical in
completing any construction project.
As
has historically been the case for the Company at each quarter-end,
there remains significant uncertainty regarding the timing of
revenue recognition of our backlog as of March 31, 2022.
We
have provided an estimate in our condensed consolidated financial
statements for when we expect to recognize revenue on our remaining
performance obligations (i.e., our Q1 2022 backlog), using separate
time bands, with respect to engineering only paid contracts and
partial equipment paid contracts. There continues to be significant
uncertainty regarding the timing of our recognition of revenue on
our Q1 2022 backlog. Refer to the Revenue Recognition
section of Note 1 in our condensed consolidated financial
statements, included as part of this Quarterly Report for
additional information on our estimate of future revenue
recognition on our remaining performance obligations.
Our
backlog, remaining performance obligations and net bookings may not
be indicative of future operating results, and our customers may
attempt to renegotiate or terminate their contracts for a number of
reasons, including delays in or inability to obtain project
financing or licensing or abandonment of the project entirely.
Accordingly, there can be no assurance that contracts included in
backlog or remaining performance obligations will generate revenues
or when the revenues will be generated. Net bookings and backlog
are considered non-GAAP financial measures, and therefore, they
should be considered in addition to, rather than as a substitute
for, our GAAP measures for recognized revenue, deferred revenue and
remaining performance obligations. Further, we can provide no
assurance as to the profitability of our contracts reflected in
remaining performance obligations, backlog and net
bookings.
Results
of Operations
Comparison of Three Months Ended March 31, 2022 and March 31,
2021
Revenues
and Cost of Goods Sold
Revenue
for the three months ended March 31, 2022 was $1,744,000, compared
to $2,367,000 for the three months ended March 31, 2021,
representing a decrease of $622,000, or 26%. The decrease was
primarily due to delays with our international supply of products
and shipments from vendors which delayed contract fulfillment and
revenue recognition on existing contracts. As a result, even though
our bookings were down, our ending backlog increased. The supply
chain impact was largely due to delays at U.S. ports, compounded by
a reduction in cargo shipped by air, a shortage of containers, and
a shortage of domestic truck delivery availability.
Cost
of revenue decreased by $368,000, or 18%, from $2,022,000 for the
three months ended March 31, 2021 to $1,654,000 for the three
months ended March 31, 2022. The decrease was primarily due to a
decrease in revenue and an increase in fixed costs as a percent of
revenue as discussed below.
The
gross profit for the three months ended March 31, 2022 was $91,000
compared to $345,000 for the three months ended March 31, 2021, a
decrease of 74%. Gross profit margin decreased by 9.4 percentage
points from 14.6% for the three months ended March 31, 2022 to 5.2%
for the three months ended March 31, 2021 primarily due to an
increase in fixed costs as a percent of revenue, as described
below.
Our
fixed costs (which include engineering, service, manufacturing and
project management salaries and benefits and manufacturing
overhead) totaled $359,000, or 21% of total revenue, for the three
months ended March 31, 2022 as compared to $337,000, or 14% of
total revenue, for the three months ended March 31, 2021. The
increase of $22,000 was primarily due to an increase in salaries
and benefits (including stock-based compensation) of $33,000,
offset by a decrease in overhead of $11,000.
Our
variable costs (which include the cost of equipment, outside
engineering costs, shipping and handling, travel and warranty
costs) totaled $1,295,000, or 74% of total revenue, in the three
months ended March 31, 2022 as compared to $1,685,000, or 71% of
total revenue, in the three months ended March 31, 2021. The
decrease in variable costs was primarily due to: (i) a decrease in
equipment costs of $376,000 driven by lower revenue, (ii) a
decrease in warranty expense of $64,000, offset by (iii) an
increase in travel expenses of $45,000.
We
continue to focus on gross margin improvement through a combination
of efforts, including more disciplined pricing, better absorption
of our fixed costs as we convert our bookings into revenue, and the
implementation over time of lower-cost supplier
alternatives.
Operating
Expenses
Operating
expenses increased to $1,702,000 for the three months ended March
31, 2022, from $1,030,000 for the three months ended March 31,
2021, an increase of $671,000, or 65%. The operating expense
increase consisted of: (i) an increase in selling, general and
administrative expenses (“SG&A expenses”) of $571,000, (ii) an
increase in advertising and marketing expenses of $74,000, and
(iii) an increase in product development expenses of
$26,000.
The
increase in SG&A expenses for the three months ended March 31,
2022 compared to the three months ended March 31, 2021, was
primarily due to: (i) an increase of $384,000 in salaries and
benefits (including stock-based compensation) and other employee
related costs, (ii) an increase of $87,000 for accounting and other
professional fees, (iii) an increase in insurance costs of $44,000,
and (iv) an increase of $50,000 for board fees and investor
relations expenses.
The
increase in marketing expenses was primarily due to (i) an increase
in salaries and benefits (including stock-based compensation) of
$51,000, and (ii) an increase in other promotional marketing
expenses of $23,000.
The
increase in product development costs was due to an increase in
salaries and benefits (including stock-based compensation) of
$26,000.
Operating
Income (Loss)
We
recognized an operating loss of $1,611,000 for the three months
ended March 31, 2022, as compared to an operating loss of $686,000
for the three months ended March 31, 2021, an increase of $926,000,
or 135%. The operating loss for the three months ended March 31,
2022 included $93,000 of non-cash, stock-based compensation and
$7,000 of depreciation and amortization expense, compared to
$59,000 of non-cash, stock-based compensation and $17,000 of
depreciation and amortization expense for the three months ended
March 31, 2021. Excluding these non-cash items, our operating loss
increased by $902,000, or 148%.
Other
Income (Expense)
We
recognized other income (net) of $188,000 for the three months
ended March 31, 2022, compared to other expense (net) of $108,000
for the three months ended March 31, 2021. Other income for the
three months ended March 31, 2022 primarily consisted of income
from an insurance settlement of $185,000. Other expense for the
three months ended March 31, 2021 consisted of $107,000 related to
the settlement of litigation with a former employee.
Net
Income (Loss)
Overall,
we recognized a net loss of $1,423,000 for the three months ended
March 31, 2022, as compared to a net loss of $793,000 for the three
months ended March 31, 2021, an increase of $630,000, or 79%. The
net loss for the three months ended March 31, 2022 included $93,000
of non-cash, stock-based compensation and $7,000 of depreciation
and amortization expense, compared to $126,000 of non-cash,
stock-based compensation and $17,000 of depreciation and
amortization expense for the three months ended March 31, 2021.
Excluding these non-cash items, our net loss increased by $673,000,
or 104%.
Financial
Condition, Liquidity and Capital Resources
Cash, Cash Equivalents
As of
March 31, 2022, we had cash and cash equivalents of $22,034,000,
compared to cash and cash equivalents of $2,160,000 as of December
31, 2021. The $19,874,000 increase in cash and cash equivalents
during the three months ended March 31, 2022, was primarily the
result of cash proceeds from the sale of common stock and warrants
of $21,711,000, offset by the redemption of series B preferred
stock and interest of $2,016,000. Our cash is held in bank
depository accounts in certain financial institutions. During the
three months ended March 31, 2022, we held deposits in financial
institutions that exceeded the federally insured amount.
As of
March 31, 2022, we had accounts receivable (net of allowance for
doubtful accounts) of $191,000, inventory (net of excess and
obsolete allowance) of $1,006,000 (including $692,000 of inventory
in transit), and prepaid expenses of $1,774,000 (including
$1,579,000 in advance payments on inventory purchases). While we
typically require advance payment before we commence engineering
services or ship equipment to our customers, we have made
exceptions requiring us to record accounts receivable, which carry
a risk of non-collectability especially since most of our customers
are funded on an as-needed basis to complete facility construction.
We expect our exposure to accounts receivable risk to increase as
we continue to pursue larger projects.
As of
March 31, 2022, we had total accounts payable and accrued expenses
of $1,389,000, deferred revenue of $5,485,000, accrued equity
compensation of $84,000, other current liabilities of $37,000 and
the current portion of operating lease liability of $112,000. As of
March 31, 2022, we had working capital of $17,948,000, compared to
a working capital deficit of $415,000 as of December 31, 2021. The
increase in our working capital was primarily related to (i) an
increase in cash of $19,874,000, (ii) an increase in inventory of
$628,000, (iii) an increase in prepaid expenses and other assets of
$551,000, offset by (iv) an increase in deferred revenue of
$2,646,000.
We
have never declared or paid any cash dividends on our common stock.
We currently intend to retain all available funds and any future
earnings for use in the operation and expansion of our business and
do not anticipate paying any cash dividends in the foreseeable
future.
Summary of Cash Flows
The
following summarizes our approximate cash flows for the three
months ended March 31, 2022 and 2021:
|
|
For the Three Months
Ended
March 31,
|
|
|
|
2022 |
|
|
2021 |
|
Net cash provided by
operating activities |
|
$ |
193,000 |
|
|
$ |
484,000 |
|
Net cash used in investing
activities |
|
|
(14,000 |
) |
|
|
(12,000 |
) |
Net cash
provided by financing activities |
|
|
19,695,000 |
|
|
|
514,000 |
|
Net increase in
cash |
|
$ |
19,874,000 |
|
|
$ |
986,000 |
|
Operating Activities
We
incurred a net loss for the three months ended March 31, 2022 of
$1,423,000 and have an accumulated deficit of $30,205,000 as of
March 31, 2022.
Cash
provided by operations for the nine months ended March 31, 2022 was
$193,000 compared to $484,000 for the three months ended March 31,
2021, a decrease of $291,000.
The decrease in cash provided by operating activities during the
three months ended March 31, 2022 as compared to the three months
ended March 31, 2021, was primarily attributable to: (i) an
increase in net loss of $630,000, (ii) an increase in cash used to
fund working capital of $361,000, and (iii) a decrease in non-cash
operating charges of $22,000.
The
increase in working capital was related to: (i) an increase in cash
of $19,874,000, (ii) an increase in inventory of $628,000, (iii) an
increase in prepaid expenses and other assets of $551,000, offset
by (iv) an increase in deferred revenue of $2,646,000.
The
decrease in non-cash operating charges was due to (i) a decrease in
amortization of ROU asset of $24,000, (ii) a decrease in the
allowance for doubtful accounts of $22,000, and (iii) an increase
in other share-based compensation of $19,000.
Investing Activities
The
$14,000 cash used in investing activities during the three months
ended March 31, 2022 was related to the purchase of property and
equipment. Cash used in investing activities during the three
months ended March 31, 2021 was related to the purchase of property
and equipment of $12,000.
Financing Activities
Cash
flows from financing activities during the three months ended March
31, 2022, was the result of cash proceeds from the sale of common
stock and warrants (net of issuance costs) of $21,711,000, offset
by a cash payment of $2,016,000 for the redemption of series B
preferred stock, including related interest.
Common Stock Equity Offering
On
February 10, 2022, the Company signed a firm commitment
underwriting agreement for the public offering of shares of common
stock and warrants, which closed on February 15, 2022. The Company
received net proceeds of approximately $21,711,000 for the sale of
5,811,138 shares of common stock and 6,572,808 warrants, each
warrant to purchase one share of common stock for five years,
exercisable immediately, at an exercise price of $5.00. The Company
also issued to the representative of the underwriters 290,557
warrants, each warrant to purchase one share of common stock at an
exercise price of $5.16, during the period commencing August 9,
2022, and expiring on February 10, 2027.
The
net proceeds from the offering will be used to advance the
Company’s organic growth and new product initiatives, to pursue
select acquisitions, and for general corporate and working capital
purposes. In connection with this offering, we received approval to
list our common stock on the Nasdaq Capital Market under the symbol
“CEAD” and our warrants under the symbol “CEADW”. As a result,
effective February 10, 2022, trading of both shares of the
Company’s common stock and certain of the Company’s warrants
commenced on the Nasdaq.
Inflation
To
date, we have
experienced and are likely to continue to face inflationary
increases on the cost of products, which may adversely affect our
margins and financial results, and the pricing of our service and
product supply contracts. The inflationary pressures are in both
the larger economy and in the industries related to building
renovations, retrofitting and new build facilities in which we
operate. This inflation is reflected in higher wages, increased
pricing of equipment and other products that we have contracted to
provide to our customers, and generally higher prices across all
sectors of the economy. As we move forward, we plan to continuously
monitor our various contract terms and may decide to add clauses
that will permit us to adjust pricing if inflation and price
increase pressures on us will impact our ability to perform our
contracts and maintain our margins.
Contractual Payment Obligations
As of
March 31, 2022, our contractual payment obligations consisted of a
building lease. Refer to Note 2 – Leases of the notes
to the condensed consolidated financial statements, included as
part of this Quarterly Report for a discussion of building
lease.
Commitments
and Contingencies
Refer
to Note 7 – Commitments and Contingencies of the notes to
the condensed consolidated financial statements, included as part
of this Quarterly Report for a discussion of commitments and
contingencies.
Off-Balance
Sheet Arrangements
We
are required to disclose any off-balance sheet arrangements that
have or are reasonably likely to have a current or future effect on
our financial condition, changes in financial condition, revenues
or expenses, results of operations, liquidity, capital
expenditures, or capital resources that are material to investors.
As of March 31, 2022, we had no off-balance sheet arrangements.
During the three months ended March 31, 2022, we did not engage in
any off-balance sheet financing activities other than those
included in the “Contractual Payment Obligations” discussed above
and those reflected in Note 7 of our condensed consolidated
financial statements.
Recent
Developments
Refer
to Note 12 - Subsequent Events of the notes to condensed
consolidated financial statements, included as part of this
Quarterly Report for certain significant events occurring since
March 31, 2022.
Critical
Accounting Estimates
This
discussion and analysis of our financial condition and results of
operations is based upon our condensed consolidated financial
statements, which have been prepared in conformity with accounting
principles generally accepted in the United States of America.
Certain accounting policies are particularly important to the
understanding of our financial position and results of operations
and require the application of significant judgment by our
management or can be materially affected by changes from period to
period in economic factors or conditions that are outside of our
control. As a result, they are subject to an inherent degree of
uncertainty. In applying these policies, management uses their
judgment to determine the appropriate assumptions to be used in the
determination of certain estimates. Those estimates are based on
our historical operations, our future business plans and projected
financial results, the terms of existing contracts, observance of
trends in the industry, information provided by our customers, and
information available from other outside sources, as appropriate.
Actual results could materially differ from those estimates. Key
estimates include: allocation of transaction prices to performance
obligations under contracts with customers, standalone selling
prices, timing of expected revenue recognition on remaining
performance obligations under contracts with customers, valuation
of intangible assets, valuation of equity-based compensation,
valuation of deferred tax assets and liabilities, warranty
accruals, accounts receivable and inventory allowances, and legal
contingencies.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT
MARKET RISK
We
are a smaller reporting company, as defined by Rule 12b-2 of the
Exchange Act, therefore are not required to provide the information
under this item.
ITEM 4. CONTROLS AND PROCEDURES
Evaluation
of Disclosure Controls and Procedures
Our
management, with the participation of our Chief Executive Officer
and our Principal Financial and Accounting Officer, has evaluated
the effectiveness of our disclosure controls and procedures (as
defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act),
as of the end of the period covered by this Quarterly Report on
Form 10-Q. Based on this evaluation, our Chief Executive Officer
and Principal Financial and Accounting Officer concluded that as a
result of material weakness in our internal control over financial
reporting as described in Item 9A of our Annual Report on Form 10-K
for the year ended December 31, 2021 filed with the SEC, our
disclosure controls and procedures were not effective as of March
31, 2022.
We
did not maintain effective controls over certain aspects of the
financial reporting process because: (i) we lack a sufficient
complement of personnel with a level of accounting expertise and an
adequate supervisory review structure that is commensurate with our
financial reporting requirements, (ii) there is inadequate
segregation of duties due to our limited number of accounting
personnel, and (iii) we have insufficient controls and processes in
place to adequately verify the accuracy and completeness of
spreadsheets that we use for a variety of purposes including
revenue, taxes, stock-based compensation and other areas, and place
significant reliance on, for our financial reporting.
We
intend to take appropriate and reasonable steps to make the
necessary improvements to remediate these deficiencies. We are
committed to continuing to improve our financial organization
including, without limitation, expanding our accounting staff and
improving our systems and controls to reduce our reliance on the
manual nature of our existing systems. However, due to our size and
our financial resources, remediating the several identified
weaknesses has not been possible and may not be economically
feasible now or in the future.
Changes
in Internal Control over Financial Reporting
There
were no changes identified in connection with our internal control
over financial reporting during the three months ended March 31,
2022, that have materially affected, or are reasonably likely to
materially affect, our internal control over financial
reporting.
PART II — OTHER INFORMATION
Item 1. Legal Proceedings
We
are not currently a party to any material legal proceedings, nor
are we aware of any pending or threatened litigation that would
have a material adverse effect on our business, operating results,
cash flows, or financial condition should such litigation be
resolved unfavorably. We have and will continue to have commercial
disputes arising in the ordinary course of our business.
Item 1A. Risk Factors
In
addition to the information set forth in this Form 10-Q, you should
also carefully review and consider the risk factors contained in
our other reports and periodic filings with the SEC, including,
without limitation, the risk factors and uncertainties contained
under the caption “Item 1A—Risk Factors” in our Annual Report on
Form 10-K for the year ended December 31, 2021 that could
materially and adversely affect our business, financial condition,
and results of operations. The risk factors discussed in that Form
10-K do not identify all risks that we face because our business
operations could also be affected by additional factors that are
not known to us or that we currently consider to be immaterial to
our operations.
Item 2. Unregistered Sales of Equity Securities and Use of
Proceeds
On
February 16, 2022, the Company agreed to convert 1,650 shares of
the Series B Preferred Stock into 362,306 shares of common stock
and 703,069 warrants. Of the warrants, 170,382 are pre-funded
warrants that vested immediately, have an indefinite term and an
exercise price of $0.01, and the balance of 532,688 warrants also
vested immediately, have a term of 5 years and have an exercise
price of $5.00. Each warrant entitles the holder to purchase one
share of common stock. The issuances were to an accredited investor
pursuant to an exemption from registration of the Securities Act
under Section 4(a)(2).
Item 3. Defaults upon Senior Securities
None.
Item 4. Mine Safety Disclosures
Not
applicable
Item 5. Other Information
None.
Item 6. Exhibits
The
documents listed in the Exhibit Index of this Form 10-Q are
incorporated by reference or are filed with this Form 10-Q, in each
case as indicated therein (numbered in accordance with Item 601 of
Regulation S-K).
SIGNATURES
Pursuant
to the requirements of Section 13 or 15(d) of the Securities
Exchange Act of 1934, the registrant has duly caused this report to
be signed on its behalf by the undersigned, thereunto duly
authorized.
|
CEA
INDUSTRIES INC. |
|
(the
“Registrant”) |
|
|
|
Dated:
May 12, 2022 |
By: |
/s/
Anthony K. McDonald |
|
|
Anthony
K. McDonald |
|
|
Chief
Executive Officer and President |
|
|
(Principal
Executive Officer) |
|
|
|
Dated:
May 12, 2022 |
By: |
/s/
Ian K. Patel |
|
|
Ian
K. Patel |
|
|
Chief
Financial Officer |
|
|
(Principal
Financial and Accounting Officer) |
EXHIBIT INDEX
* |
Filed
herewith. |
** |
Furnished
herewith. |
CEA Industries (NASDAQ:CEAD)
Historical Stock Chart
From Feb 2023 to Mar 2023
CEA Industries (NASDAQ:CEAD)
Historical Stock Chart
From Mar 2022 to Mar 2023